UNITED STATES


SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-K

(Mark One)

ý(Mark One)
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2010

OR

o
For the fiscal year ended: December 31, 2011
OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                 to                     
Commission file number: 0-11668

For the transition period from                 to

Commission file number: 0-11668
Photonic Products Group,

Inrad Optics, Inc.

(Exact name of registrant as specified in its charter)

New Jersey 22-2003247
State or other jurisdiction of incorporation or organization (I. R. S. Employer Identification No.)

181 Legrand Avenue, Northvale, NJ 07647
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code 201-767-1910

Securities registered pursuant to Section 12(b) of the Act:None

  Name of each exchange
Title of each class on which registered
 

Securities registered pursuant to section 12(g) of the Act:

Common stock, par value $.01 Per Share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined inRule 405 of the Securities Act. Yeso¨.      No ýx.

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes  o¨.      No ýx.

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YesxNo¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                                                                                                                      Yesýx          Noo¨

Indicate by check mark if disclosure of delinquent filers pursuant toItem 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference inPart III of this Form 10-K or any amendment to this Form 10-K.o¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated file, or a smaller reporting company. See definition of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b2 of the Exchange Act. (Check one):

Large accelerated filer  o¨
 
Accelerated filer  o¨
 
Non-accelerated filer  o¨
 
Smaller reporting company  ýx

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o   No ý

Yes¨Nox

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $8,454,339$9,434,493 (For purposes of determining this amount, only directors, executive officers and shareholders with voting power of 10% or more of our stock have been deemed affiliates.)

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

Common Shares outstanding as of March 30, 2011

11,687,353
29, 2012 - 11,864,124 shares

Documents Incorporated by Reference

Reference: Portions of the registrant’sregistrant's definitive proxy statementProxy Statement for the 2012 Annual Meeting of Shareholders, to be filed with the Commission not later than 120 days after the endclose of the registrant’s fiscal year, covered by this report arehave been incorporated by reference, in whole or in part, into Part III.
III Items 10, 11, 12, 13 and 14 of this Annual Report on 10-K.







Photonic Products Group, Inc.

INDEX

Inrad Optics, Inc.

INDEX

Part I

  
Item 1.Business12
Item 1A.Risk Factors 57
Item 1B.Unresolved Staff Comments 78
Item 2.Properties 78
Item 3.Legal Proceedings 79
Item 4.ReservedMine Safety Disclosures9
 7
Part II  
Item 5.Market for Registrant’s Common Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities 810
Item 6.Selected Financial Data 911
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operation 1011
Item 7A.Quantitative and Qualitative Disclosures about Market Risk 1617
Item 8.Financial Statements and Supplementary Data 1617
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 1617
Item 9AControls and Procedures 1617
Item 9BOther Information 1718
Part III
  
Item 10.Directors, Executive Officers and Corporate Governance 1819
Item 11.Executive Compensation 1819
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 1819
Item 13.Certain Relationships and Related Transactions, and Director Independence 1819
Item 14.Principal Accounting Fees and Services 1819
Part IV
  
Item 15Exhibits and Financial Statement Schedules 1920
Signatures 2021

1

i

PART 1

Caution Regarding Forward Looking Statements

This Annual Report contains forward-looking statements as that term is defined in the federal securities laws. The Company wishes to insure that any forward-looking statements are accompanied by meaningful cautionary statements in order to comply with the terms of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. The events described in the forward-looking statements contained in this Annual Report may not occur. Generally, these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of the Company’s plans or strategies, or projections involving anticipated revenues, earnings, or other aspects of the Company’s operating results. The words “may”, “will”, “expect”, “believe”, “anticipate”, “project”, “plan”, “intend”, “estimate”, and “continue”, and their opposites and similar expressions are intended to identify forward-looking statements. The Company cautions you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks, and other influences, many of which are beyond the Company’s control, that may influence the accuracy of the statements and the projections upon which the statements are based. Factors which may affect the Company’s results include, but are not limited to, the risks and uncertainties discussed in Items 1A, 7 and 7A. Any one or more of these uncertainties, risks, and other influences could materially affect the Company’s results of operations and whether forward-looking statements made by the Company ultimately prove to be accurate. Readers are further cautioned that the Company’s financial results can vary from quarter to quarter, and the financial results for any period may not necessarily be indicative of future results. The foregoing is not intended to be an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by the Company. The Company’s actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward looking statements, whether from new information, future events, or otherwise, except as otherwise required by law.

Item 1.Business
Photonic Products Group,

Inrad Optics, Inc. (the “Company” or “PPGI”, “Inrad”), was incorporated in New Jersey in 1973,1973. The Company develops, manufactures and markets products and services for use in photonics industry sectors via three brand names (“Inrad”distinct but complimentary product areas - “Crystals and Devices”, “Laser“Custom Optics”, “MRC”).   and “Metal Optics.”

Prior to September 2003 PPGIthe Company was named and did business solely as Inrad, Inc. Company management,In 2003, the Board of Directors and shareholders approved thea name change in 2003.

to Photonic Products Group, Inc. (PPGI) and then to Inrad Optics, Inc. on January 18, 2012.

In November 2003, the Company purchased the assets and certain liabilities of Laser Optics, Inc. of Bethel, CT. Laser Optics, Inc. was a custom optics and optical coating services provider, in business since 1966. PPGI integrated the Bethel team and their operations into the Company’s Northvale, NJ operations in mid-2004. This integration leveraged Inrad’s original crystalline products with the custom optics and optical coating capabilities of Laser Optics to provide an enhanced set of product offerings.

In October 2004, the Company acquired MRC Precision Metal Optics, Inc. (“MRC”) of Sarasota, Florida, a precision metal optics and diamond-turned aspheric optics manufacturer, specializing in CNC and single point diamond machining, optical polishing, nickel plating, aluminum, AlBeMet™ and berylliumBeryllium machining.


In 2011, the Company undertook a significant review of its brand position within the marketplace and concluded that the Company’s name, “Photonics Products Group, Inc.”, due to its composition of common words within our industry, had not achieved the anticipated level of brand equity since its inception in 2003.  In order to solve this significant business issue, the Company developed and is currently implementing a strategic marketing plan around the brand name of Inrad Optics.  In January 2012, the Company’s shareholders approved a name change to Inrad Optics, Inc.Changing the Company’s name to Inrad Optics, Inc. leverages the positive historical and current brand equity of the Inrad name and more clearly communicates the Company’s principal business activities to both our marketplace and the investment community.

The original Inrad organization“Inrad” name was knownrecognized as one of the photonic industry’s seminal crystalline products companies. Photonic Products Group, Inc.The Company is now a vertically integrated organization specializing in crystal-based optical components and devices, custom optical components from both glass and metal, and precision optical and opto-mechanical assemblies.


Manufacturing capabilities include solution and high temperature crystal growth, extensive optical fabrication capabilities, including precision diamond turning and the ability to handle large substrates, optical coatings and in-process metrology expertise.

PPGI’s

Inrad Optics’ customers include leading corporations in the defense, aerospace, laser systems, process control and metrology sectors of the photonics industry, as well as the U.S. Government, National Laboratories and Universities worldwide.

Administrative, engineering and manufacturing operations are in a 42,000 square foot building located in Northvale, New Jersey, about 15 miles northwest of New York City, and in a 25,000 square foot building located in Sarasota, FL. The headquarters of the Company are located in the Northvale facility.

The products produced by PPGI’sInrad Optics, Inc. fall into two main categories: Optical Components and Laser System Devices and Instrumentation.

The Optical Components segment of the business is heavily focused on custom optics manufacturing. The Company specializes in high-end precision components. It develops, manufactures and delivers precision custom optics and thin film optical coating services through its LaserCustom Optics and MRC brand names.  Glass,Metal Optics operations.Glass, metal, and crystal substrates are processed using modern manufacturing equipment, complex processes and techniques to manufacture components, deposit optical thin films, and assemble sub-components used in advanced photonic systems. The majority of custom optical components and optical coating services supplied are used in inspection, process control systems, defense and aerospace electro-optical systems, laser system applications, industrial scanners, and medical system applications.

1

The Laser System Devices and Instrumentation category includes the growth and fabrication of crystalline materials with electro-optic (EO), and non-linear and optical properties for use in both standard and custom products. This category also includes the manufactured crystal based devices and associated instrumentation. The majority of crystals, crystal components and laser devices manufactured are used in laser systems, defense EO systems, medical lasers and R&D applications by engineers within corporations, universities and national laboratories.

The following table summarizes the Company’s productnet sales by product categories during the past three years. Laser System Devices and Instrumentation includes all non-linear and electro-optical crystal components.


  Years Ended December 31, 
  2010  2009  2008 
Category Sales  %  Sales  %  Sales  % 
Optical Components $10,115,000   92  $10,350,000   94  $14,750,000   90 
Laser System Devices and Instrumentation  939,000   8   701,000   6   1,551,000   10 
TOTAL $11,054,000   100  $11,051,000   100  $16,301,000   100 

  Years Ended December 31, 
  2011  2010  2009 
Category (In thousands) Net Sales  %  Net Sales  %  Net Sales  % 
Optical Components $11,812   90  $10,115   92  $10,350   94 
Laser System Devices and Instrumentation  1,365   10   939   8   701   6 
TOTAL $13,177   100  $11,054   100  $11,051   100 

Products Manufactured by the Company

Optical Components

a)           Custom Optics and Optical Coating Services

a)Custom Optics and Optical Coating Services

Manufacturing of high-performance custom optics is a major product area for PPGI,Inrad Optics, Inc. and is addressed in the marketplace underby each of the Inrad, Laserproduct groups - Crystals and Devices, Custom Optics and MRC brand names.

Metal Optics.

The LaserCustom Optics brand focusesproduct linefocuses on products manufactured to specific customer requirements. It specializes in the manufacture of optical components, optical coatings (ultra-violet wavelengths through infra-red wavelengths) and subassemblies for the military, aerospace, industrial and medical marketplace. Planar, prismatic and spherical components are fabricated from glass and synthetic crystals, including fused silica, quartz, germanium, zinc selenide, zinc sulfide, magnesium fluoride and silicon. Components consist of mirrors, lenses, prisms, waveplates, polarizing optics, monochrometers, x-ray mirrors, and cavity optics for lasers.

Most optical components and sub-assemblies require thin film coatings on their surfaces. Depending on the design, optical coatings can refract, reflect, or transmit specific wavelengths. LaserThe Custom Optics optical coating specialties include high laser damage resistance, polarizing, highly reflective, anti-reflective, infra-red, and coating to complex multi-wavelength requirements on a wide range of substrate materials. Coating deposition process technologies employed included electron beam, thermal, and ion assist.

The MRC metal opticsMetal Optics product line is manufactured in our facility in Sarasota, Florida which is a fully integrated precision metal optics and optical assembly manufacturer.  The facilityoperation which employs high precision CNC and diamond machining, polishing, plating of aluminum, AlBeMet™, beryllium and stainless steel. MRCThe Metal Optics product line offers opto-mechanical design and assembly services as part of its manufactured deliverables.   MRC has developed processes todeliverables and can support prototyping through production of large and small metal mirrors, thermally stable optical mirrors, low RMS surface finish polished mirrors, diamond machined precision aspheric and planar mirrors, reflective porro prisms, and arc-second accuracy polygons and motor assemblies. Plating specialties include void-free gold and electro-less nickel.

b)           UV Filter Optical Components

b)UV Filter Optical Components

The Inrad crystal componentsCrystals and Devices product line includes filter materials of both patented and proprietary materials with unique transmission and absorption characteristics. These materials are used in critical applications in defense systems such as missile warning sensors. Such materials include nickel sulfate, and proprietary materials such as UVC-7 and LAC.

3
2

Laser Devices and Instrumentation

The Inrad brand name coversCrystals and Devices product line consists of crystal-based products that are used in, or alongside, laser systems. Developing growth processes for high quality synthetic crystals lies at the heartis a core competency of the Inrad laser deviceCrystals and Devices manufacturing team. These crystals are embedded in the value added devices and instrumentation products.  Inrad products are manufactured in an extensiveour crystal growth facility. Products producedproduction facility and include crystals for wavelength conversion, modulation and polarization, Pockels cells, and wavelength conversion instruments. In addition to the filter materials consumed by the UV Filter Optical components described above, current materials produced include Beta Barium Borate (BBO), Lithium Niobate, Zinc Germanium DiPhosphide, and Potassium Dihydrogen Phosphate and Potassium Dideuterium Phosphate. Applications for these materials include defense, homeland security, surgical lasers, and industrial processing lasers. The InradCrystals and Devices team is also engaged in ongoing R & D efforts to develop new materials for evolving applications and offers contract growth of crystalline materials to customer specifications. Some of the major products sold underproduced for the Inrad brandphotonics marketplace include:

a)           Crystal Components

a)Crystal Components

The Company grows and fabricates electro-optic and nonlinear crystal devices for altering the intensity, polarization or wavelength of a laser beam. Other crystal components, produced by PPGIas part of the Crystals and Devices product line, are used in laser research and in commercial laser systems.

b)           Pockels Cells

b)Pockels Cells

A line of Pockels cells and associated electronics is manufactured for sale under the Inrad brand name.in multiple market sectors. Pockels cells are devices that include one or more crystal components and are used in applications that require fast switching of the polarization direction of a beam of light. These uses include Q-switching of laser cavities to generate pulsed laser light, coupling light into and out from regenerative amplifiers, and light intensity modulation. These devices are sold on an OEM basis to medical and industrial laser original equipment manufacturers, researcher institutes and laser system design engineers.

c)           Harmonic Generation Systems

c)Harmonic Generation Systems

The Company designs and manufactures harmonic generation laser systems and accessories for sale under the Inrad brand name.laser research R & D community. Harmonic generation systems enable the users of lasers to convert the fundamental frequency of the laser to another frequency required for specific applications. Harmonic generators are used in spectroscopy, semiconductor processing, medical lasers, optical data storage and scientific research.

Many commercial lasers have automatic tuning features, allowing them to produce a range of frequencies. The Inrad AutotrackerCompany’s“Autotracker” product, when used in conjunction with these lasers, automatically generates tunable ultraviolet light or infrared light for use in spectroscopic applications.

Sales by Market

Photonics, by its nature,

The photonics industry serves a very broad, fragmented and expanding set of markets. As technologies are discovered, developed and commercialized, the applications for photonic systems and devices, and the components embedded within those devices, grow across traditional market boundaries. While PPGI’s businessa significant part of the Company’sbusiness remains firmly in the defense and aerospace markets, other markets served include the OEM medical and industrial laser market, and the OEM metrology and process control market.market, university research institutes and national labs worldwide. Scanning, detection and imaging technologies for homeland security and health care markets are beginning to provide opportunities for PPGI products moving forward,Inrad Optics, Inc., and these new sectors are expected to provide increasing opportunitiestoaccount for PPGI’s set offuture growth and demand for Inrad Optics, Inc.’s products and capabilities.

In 2011, 2010 2009 and 20082009 the Company’s product sales were made to customers in the following market areas:

Market  (In thousands) 2010  2009  2008  
Defense/Aerospace $6,968(63)% $7,454(68)% $10,329(63)%
Process control & metrology  2,751(25)%  2,339(21)%  4,629(29)%
Laser systems and other  796(7)%  766(7)%  1,077(7)%
Universities & national laboratories  539(5)%  492(4)%  203(1)%
Total $11,054(100)% $11,051(100)% $16,301(100)%
Major market sectors currently served by the Company include defense and aerospace, process control & metrology, laser systems including various other markets not separately classified , and to a lesser extent, universities and national laboratories.

Market  (In thousands) 2011  2010  2009 
Defense/Aerospace $6,734   (51)% $6,968   (63)% $7,454   (68)%
Process control & metrology  4,752   (36)%  2,751   (25)%  2,339   (21)%
Laser systems and other  1,255   (10)%  796   (7)%  766   (7)%
Universities & national laboratories  436   (3)%  539   (5)%  492   (4)%
Total $13,177   (100)% $11,054   (100)% $11,051   (100)%

Defense and Aerospace

This area consists of sales to OEM defense electro-optical systems and subsystems manufacturers, manufacturers of non-military satellite-based electro-optical systems and subsystems, and direct sales to governments where the products have the same end-use.

End-use applications for PPGI’sInrad Optics’ products in the defense and aerospace sector include military laser systems, military electro-optical systems, satellite-based systems, and missile warning sensors and systems that protect aircraft. The dollar volume of shipments of product within this sector depends in large measure on the U.S. Defense Department budget and its priorities, that of foreign governments, the timing of their release of contracts to their prime equipment and systems contractors, and the timing of competitive awards from this customer community to the Company.

Defense/Aerospace sector sales represented approximately 63%51%, 68%63% and 63%68% of sales in 2011, 2010 2009 and 2008.2009. In spite of the decreasedecreases in 2011 and 2010, the Company believes that the defense and aerospace sector will continue to represent a significant market for the Company’s products and offers an ongoing opportunity for growth given the Company’s capabilities in specialty crystal, glass and metal precision optics.

3

Process Control and Metrology

This area consists of customers who are OEM manufacturers of capital equipment used in manufacturing process implementation and control, optics-based metrology and quality assurance, and inventory and product control equipment. Examples of applications for such equipment include semiconductor (i.e., chip) fabrication and testing and inventory management and distribution control.

Sales in the Process Control and Metrology market sector, the Company’s second largest market, increased in 2010,2011, both as a percentage of total sales and in relative sales dollars, compared to 20092010 This increase in this sector correlates with the recovery of the semi-conductor market and themarket. The Company believes that the optical and x-ray inspection segment of the semiconductor industry offers continued opportunities which match its capabilities in precision optics, crystal products, and monochrometers.

Laser Systems and Other

This market consists principally of customers who are OEM manufacturers of industrial, medical, and R&D lasers which the Company serves as an OEM supplier of standard and custom optical components and laser accessories, as well as, representing market areas that while they may be the object of penetration plans by the Company, are not currently large enough to list individually. ThisSales to this market has remained relatively unchanged, at 7% ofincreased in 2011 mainly due to the Company’s sales, over the last three years.

increased demand for custom components from new customers.

The Company also serves the industrial and medical laser industry as an OEM supplier of standard and custom optical components and laser accessories.

Universities and National Laboratories

These sales consist of product sales to researchers at suchvarious educational and research institutions.

Sales to customers within the University and National Laboratories market sector consist primarily of the Company’s legacy systems, Pockels cells and related repairs. Although sales for 2011 decreased as a percentage of total sales from 2010, the total dollar amount from sales to this market remained relatively stable over the past three years and is dependent on research projects and the availability of funding for such projects. In 2010, sales increases reflect the availability of stimulus funding for the National Labs. This follows a year over year sales increase inLabs following 2009 when sales were $492,000 and 4% of sales over 2008 sales of $203,000, representing 1% of total sales.

Major Customers

The

Historically, the Company’s sales have been concentrated within a small number of customers, although the top customers have historically varied from year to year. In 2011, the Company had sales to three major domestic customers whichthat accounted for 15.3%20.9%, 15.4% and 10.8%, of sales. In 2011, the largest account was an international customer that is in the process control and 10.3% of sales in 2010.  Each customer is anmetrology industry. The other two major customers are electro-optical systems divisiondivisions of a major U.S. defense corporationindustry corporations who manufacturesmanufacture systems for U.S. and allied foreign governments. In 2009,2010, the sametop three customers represented 17.7%15.3%, 9.8%10.3% and 4.7%10.1% of sales, respectively

respectively.

During the past three years, sales to the Company’s top five customers represented approximately 53.3%58.1%, 55.3%54.3% and 58.8%55.3% of sales, respectively. These top customers have been manufacturers either in the Defensedefense sector or the process control and metrology sector. Given the concentration of sales within a small number of customers, the loss of any of these customers would have a significant negative impact on the Company and its business units.

Export Sales

The Company’s export sales, which are primarily to customers in countries within Europe, Asia and Japan, amounted to approximately 14.9%22.8%, 12.5%14.9%, and 5.2%12.5% of product sales in 2011, 2010 and 2009, and 2008, respectively.

5

Long-Term Contracts

Certain of the Company’s agreements with customers provide for periodic deliveries at fixed prices over a long period of time. In such cases, as in most other cases as well, the Company attempts to obtain firm price commitments, as well as, cash advances from theseits suppliers for the purchase of the materials necessary to fulfill the order.

Marketing and Business Development

The Company’sCompany markets its products for all three brands, domestically, through the coordinated efforts of the sales, marketing and customer service teams.

The Company has moved towards a strategy of utilizing these combined sales and marketing resources for cross-selling all products, across all business lines. This strategy is well suited to the diverse and fragmented markets that utilize photonic technologies in multiple form factors.

Independent sales agents are used in countries in major non-U.S. markets, including Canada, UK, the EU,United Kingdom, the European Union, Israel, and Japan.

All sales

Sales and marketing efforts of all product lines and all trade show participation, internet-based marketing, media and non-media advertising and promotion, and international sales representative and distributor relationships are coordinated at the corporate level under the auspices of the corporate Vice President – Marketing and Sales.

4

In 2011, the Company undertook a significant marketing effort in the form of a corporate name change and a new branding strategy around the “Inrad Optics” name which was supported by the development of a completely new website and other brand identity marketing efforts.

Backlog

The Company’s order backlog at December 31, 20102011 was $5,407,000,$5,021,000, essentially all of which is expected to be shipped in 2011.2012. The Company’s order backlog as of December 31, 2010 and 2009 was $5,047,000 and 2008 was $4,359,000, and $6,102,000, respectively.

Competition

Within each product category in which the Company’s business units are active, there is competition.

Changes in the Photonicsphotonics industry have had an effect on suppliers of custom optics. As end users have introduced products requiring large volumes of optical components, suppliers have responded either by staying small and carving out niche product areas, or by ramping up manufacturing capacity and modernizing their manufacturing methods to meet higher volume production rates. Additionally the availability of an increasingly large variety of inventoried inexpensive catalog optics has led some OEM manufacturers to “design in” these cost-effectivelow-cost solutions rather than utilizing custom designed and manufactured products.

Competition for the Company’s lasercrystal devices and instrumentation is limited, but competitors’ products are generally lower priced.priced for OEM quantities. The Company’s laser devices are considered to be high quality and generally offer a combination of features not available elsewhere. BecauseAs a result of the Company’s in-house crystal growth capability, this area of the business is highly vertically integrated, providing a competitive advantage over other suppliers.

Our metal optics product line has several key competitors who are larger and better equipped to compete on high volume work. There are also several large and small competitors who compete with our products on large form factor optics. The Company has made recent inroads within this competitive landscape, and is building brand awareness in the marketplace.

For crystal products, price, quality, delivery and customer service are market drivers. With advancing globalization, many of the Company’s competitors who supply non-linear optical crystals are located overseas, and can offer significantly reduced pricing for some crystal materials. On many occasions, the quality of the crystal component drives the ultimate performance of the component or instrument into which it is installed. Quality and technical support are considered to be valuable attributes for a crystal supplier by some, but not all, OEM customers.

Although price is a principal factor in many product categories, competition is also based on product design, performance, customer confidence, quality, delivery, and customer service. Based on its performance to date, the Company believes that it can continue to compete successfully, although no assurances can be given in this regard.

Employees

As of the close of business on March 29, 2011,27, 2012, the Company had 8381 full-time employees.

Patents and Licenses

The Company mainly relies on its manufacturing and technological expertise, know-how and trade secrets rather than onin addition to its patents, to maintain its competitive position in the industry. The Company takes precautionary and protective measures to safeguard its technical design and manufacturing processes. The Company executes nondisclosure agreements with its employees and customers, where appropriate.

Regulation

Foreign sales of certain of the Company’s products to certain countries may require export licenses from the United States Department of Commerce. Such licenses are obtained when required. All requested export licenses of PPGIInrad Optics products have been granted or deemed not-required.

ITAR regulations govern much of the PPGICompany’s domestic defense sector business, and the Company is well versed incapable of handling its customers’ technical information under these regulations. PPGIInrad Optics, Inc. is registered with the Directorate of Defense Trade Controls, and utilizes a supplier base of similarly registered companies.

There are no other federal regulations or any unusual state regulations that directly affect the sale of the Company’s products other than those environmental compliance regulations that generally affect companies engaged in manufacturing operations in New Jersey and Florida.

Item 1A.Risk Factors

The Company cautions investors that its performance (and, therefore, any forward looking statement) is subject to risks and uncertainties. Various important factors, including but not limited to the following, may cause the Company’s future results to differ materially from those projected in any forward looking statement.

a)As general economic conditions deteriorate, the Company’s financial results may suffer

Significant economic downturns or recessions in the United States, Europe or Asia could adversely affect the Company’s business by causing a temporary or longer term decline in demand for the Company’s goods and services and thus its revenues.

5

b)The Company has exposure to Government Markets

Sales to customers in the defense industry represent a significant part of our business. These customers in turn generally contract with government agencies. Most governmental programs are subject to funding approval and can be modified or terminated with no warning upon the determination of a legislative or administrative body. The recent economic crisis had significant effects on government spending and it is particularly difficult, at this time, to assess how this will continue to impact our defense industry customers and the timing and volume of business we do with them, in future periods. The loss or failure to obtain certain contracts or a loss of a major government customer could have a material adverse effect on our business, results of operations or financial condition.

c)The Company’s revenues are concentrated in its largest customer accounts

For the year ended December 31, 2010,2011, five customer accounts represented approximately 53%58% of total revenues, and three customers individually accounted for more than 10% of revenues. These three customers each represented approximately 15%21%, 11%15% and 10%11% of sales, respectively. Since we are a supplier of custom manufactured components to OEM customers, and have a number of large customers in both the commercial and defense markets the relative size and identity of our largest customer accounts changes somewhat from year to year. In the short term, the loss of any of these large customer accounts or a decline in demand in the sectorsmarkets which they represent could have a material adverse effect on business, our results of operations, and our financial condition.

d)The Company depends on, but may not succeed in, developing and acquiring new products and processes

In order to meet the Company’s strategic objectives, the Company needs to continue to develop new processes, to improve existing processes, and to manufacture and market new products. As a result, the Company may continue to make investments in the future in process development and additions to its product portfolio. There can be no assurance that the Company will be able to develop and introduce new products or enhancements to its existing products and processes in a way that achieves market acceptance or other pertinent targeted results. The Company also cannot be sure that it will have the human or financial resources to pursue or succeed in such activities.

e)The Company’s business success depends on its ability to recruit and retain key personnel

The Company depends on the expertise, experience, and continuing services of certain scientists, engineers, production and management personnel, and on the Company’s ability to recruit additional personnel. There is competition for the services of these personnel, and there is no assurance that the Company will be able to retain or attract the personnel necessary for its success, despite the Company’s effort to do so. The loss of the services of the Company’s key personnel could have a material adverse effect on its business, on its results of operations, or on its financial condition.

f)The Company may not be able to fully protect its intellectual property

The Company currently holds one material patent applicable to an important product, but does not in general rely on patents to protect its products or manufacturing processes. The Company generally relies on a combination of trade secret and employee non-competition and nondisclosure agreements to protect its intellectual property rights. There can be no assurance that the steps the Company takes will be adequate to prevent misappropriation of the Company’s technology. In addition, there can be no assurance that, in the future, third parties will not assert infringement claims against the Company. Asserting the Company’s rights or defending against third-party claims could involve substantial expense, thus materially and adversely affecting the Company’s business, results of operations or financial condition.

g)Many of the Company’s customer’s industries are cyclical

The Company’s business is significantly dependent on the demand its customers experience for their products. Many of their end users are in industries that historically have experienced a cyclical demand for their products. The industries include but are not limited to, the defense electro-optics industry and the manufacturers of process control capital equipment for the semiconductor tools industry. As a result, demand for the Company’s products are subject to cyclical fluctuations, and this could have a material adverse effect on our business, results of operations, or financial condition.

h)The Company’s manufacturing processes require products from limited sources of supply

The Company utilizes many relatively uncommon materials and compounds to manufacture its products. Examples include optical grade quartz, specialty optical glasses, scarce natural and manmade crystals, beryllium and its alloys, and high purity chemical compounds. Failure of theThe Company’s suppliers could fail to deliver sufficient quantities of these necessary materials on a timely basis, or to deliver contaminated or inferior quality materials, or to markedly increase their pricesprices. Any such actions could have an adverse effect on the Company’s business, despite itsthe Company’s efforts to secure long term commitments from the Company’sits suppliers. Adverse results might include reducing the Company’s ability to meet commitments to its customers, compromising the Company’s relationship with its customers, adversely affecting the Company’s ability to meet expanding demand for its products, or causing the Company’s financial results to deteriorate.

6

i)The Company faces competition

The Company encounters substantial competition from other companies positioned to serve the same market sectors that the Company serves. Some competitors may have financial, technical, capacity, marketing or other resources more extensive than ours, or may be able to respond more quickly than the Company to new or emerging technologies and other competitive pressures. Some competitors have manufacturing operations in low-cost labor regions such as the Far East and Eastern Europe and can offer products at lower prices than the Company. The Company may not be successful in winning orders against the Company’s present or future competitors, and competition may have a material adverse effect on our business, results of operations or financial condition.

j)The Company’s stock price may fluctuate widely

The Company’s stock is thinly traded. Many factors, including, but not limited to, future announcements concerning the Company, its competitors or customers, as well as quarterly variations in operating results, announcements of technological innovations, seasonal or other variations in anticipated or actual results of operations, changes in earnings estimates by analysts or reports regarding the Company’s industries in the financial press or investment advisory publications, could cause the market price of the Company’s stock to fluctuate substantially. In addition, the Company’s stock price may fluctuate widely for reasons which may be unrelated to operating results. These fluctuations, as well as general economic, political and market conditions such as recessions, military conflicts, or market or market-sector declines, may materially and adversely affect the market price of the Company’s Common Stock. In addition, any information concerning the Company, including projections of future operating results, appearing in investment advisory publications or on-line bulletin boards or otherwise emanating from a source other than the Company could in the future contribute to volatility in the market price of the Company’s Common Stock.

Item 1B.Unresolved Staff Comments

Not applicable

Item 2.Properties

Administrative, engineering and manufacturing operations are housed in a 42,000 square foot building located in Northvale, New Jersey and in a 25,000 square foot building located in Sarasota, Florida. The headquarters of the Company are in its Northvale facility. On November 1, 2010,2011, the Company exercisednegotiated a change to the final optionrate on its Northvale lease extendingand extended the term for an additional two years tountil October 31, 2012.

Photonic Products Group, Inc’s2013. The Company also has the option of renewing the lease for one year, at fixed terms, through October 31, 2014.

The Company’s wholly-owned subsidiary, MRC Precision Metal Optics Inc., (DBA Inrad Optics) has its manufacturing operations in a leased facility located in the Sarasota, Florida facility pursuant to a net lease expiring on August 31, 2013.

These facilities are adequate to meet current and future projected production requirements.

The total rent for these leases was approximately $519,000, $569,000 and $582,000 in 2011, 2010 and $588,000 in 2010, 2009, and 2008, respectively. The Company also paid real estate taxes and insurance premiums that totaled approximately $162,000 in 2011, $165,000 in 2010 and $172,000 in 2009 and $179,000 in 2008.

2009.

Item 3.Legal Proceedings

There are no legal proceedings involving the Company as of the date hereof.

Item 4.ReservedMine Safety Disclosures
None
7

Not Applicable

PART II

Item 5.Market for Registrant’s Common Equity and Related Stockholder Matters
a)           Market Information

a)Market Information

The Company’s Common Stock, with a par value of $0.01 per share, is traded on the OTC Bulletin Board under the symbol PHPG.

The Company has applied for a new symbol to reflect its new name of Inrad Optics, Inc.

The following table sets forth the range of high and low closing prices for the Company’s Common Stock in each fiscal quarter from the quarter ended March 31, 20092010 through the quarter ended December 31, 2010,2011, as reported by the National Association of Securities Dealers NASDAQ System. Such over-the-counter quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

  Price 
  High  Low 
Quarter ended December 31, 2010 $1.05  $0.90 
Quarter ended September 30, 2010  1.15   0.97 
Quarter ended June 30, 2010  1.15   1.00 
Quarter ended March 31, 2010  1.35   0.90 
Quarter ended December 31, 2009  1.50   1.00 
Quarter ended September 30, 2009  1.50   0.96 
Quarter ended June 30, 2009  1.90   1.27 
Quarter ended March 31, 2009  2.00   1.50 

  Price 
  High  Low 
       
Quarter ended December 31, 2011 $1.01  $0.95 
         
Quarter ended September 30, 2011  1.03   0.95 
         
Quarter ended June 30, 2011  1.25   0.95 
         
Quarter ended March 31, 2011  1.10   0.90 
         
Quarter ended December 31, 2010  1.05   0.90 
         
Quarter ended September 30, 2010  1.15   0.97 
         
Quarter ended June 30, 2010  1.15   1.00 
         
Quarter ended March 31, 2010  1.35   0.90 

As of March 29, 201127, 2012 the Company’s closing stock price was $1.03$0.95 per share.

b)           Shareholders

b)Shareholders

As of March 15, 2010,27, 2012, there were approximately 146145 shareholders of record of our Common Stock. The number of shareholders of record of common stock was approximated based upon the Shareholders’ Listing provided by the Company’s Transfer Agent. As of the same date, the Company estimates that there are an additional 590349 beneficial shareholders.

c)           Dividends

c)Dividends

The Company has not historically paid cash dividends. Payment of cash dividends is at the discretion of the Company’s Board of Directors and depends, among other factors, upon the earnings, capital requirements, operations and financial condition of the Company. The Company does not anticipate paying cash dividends in the immediate future.

d)           Recent Sales of Unregistered Securities

d)Recent Sales of Unregistered Securities

There were no sales of unregistered securities during 2010.

8

e)           the fourth quarter of 2011.

e)Securities Authorized for Issuance under Equity Compensation Plans

  Number of securities to be issued upon exercise of outstanding options, warrants and rights  Weighted-average exercise price of outstanding options, warrants and rights  Number of securities remaining for future issuance under equity compensation plans (1) 
2000 Equity Compensation Program approved by shareholders  800,474  $1.13    
2010 Equity Compensation Program approved by shareholders  5,000  $1.00   3,995,000 

(1)The 2000 Equity Compensation Program expired on June 2, 2010 but each outstanding option, warrant and right granted under the Program shall expire on the date determined under the terms of the original award, which in no event shall exceed 10 years.  The 2010 Equity Compensation Program was adopted by the Company’s shareholders at the Annual Meeting held on June 2, 2010.  Under this Program, an aggregate of up to 4,000,000 shares of common stock may be granted.Plans

  Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights
  Weighted-average
exercise price of
outstanding
options, warrants
and rights
  Number of securities
remaining for future issuance
under equity compensation
plans (1)
 
          
2000 Equity Compensation Program approved by shareholders  669,676  $1.05    
             
2010 Equity Compensation Program approved by shareholders  425,000  $0.92   3,590,000 

Item 6.Selected Financial Data

The following data is qualified in its entirety by the financial statements presented elsewhere in this Annual Report on Form 10-K.

     As of December 31, or    
     For the Year Ended December 31,    
  2010  2009  2008  2007  2006 
                
Revenues $11,054,178  $11,051,127  $16,301,209  $15,099,878  $13,921,127 
Net (loss) income  (733,813)  (2,799,992)  1,098,421   1,880,081   772,266 
Net (loss) income applicable to common shareholders $(733,813) $(2,799,992) $1,098,421  $1,641,914  $537,766 
Earnings per share                    
Basic (loss) earnings  per share  (0.06)  (0.25)  0.10   0.19   0.07 
Diluted (loss) earnings per share  (0.06)  (0.25)  0.08   0.13   0.06 
Weighted average shares                    
Basic  11,522,297   11,331,258   10,902,061   8,609,822   7,572,637 
Diluted  11,522,297   11,331,258   15,619,304   13,777,114   11,915,090 
Common stock dividends on Preferred shares           238,167   234,500 
Total assets  12,621,803   12,610,740   15,732,149   16,077,947   15,316,260 
Long-term obligations (1)  3,960874   3,819,946   3,678,663   3,665,730   6,824,767 
Shareholders’ equity  7,373,752   7,777,715   10,124,175   7,712,799   5,236,703 

(1)Prior year amounts have been reclassified to conform with the current years’ presentation
9

  As of December 31, or 
  For the Year Ended December 31, 
  2011  2010  2009  2008  2007 
                
Revenues $13,177,194  $11,054,178  $11,051,127  $16,301,209  $15,099,878 
                     
Net income (loss)  164,746   (733,813)  (2,799,992)  1,098,421   1.880,081 
                     
Net income (loss) applicable to common shareholders $164,746  $(733,813) $(2,799,992) $1,098,421  $1,641,914 
                     
Earnings per share                    
Basic earnings (loss) per share  0.01   (0.06)  (0.25)  0.10   0.19 
Diluted earnings (loss) per share  0.01   (0.06)  (0.25)  0.08   0.13 
                     
Weighted average shares          ��         
Basic  11,658,891   11,522,297   11,331,258   10,902,061   8,609,822 
Diluted  11,753,669   11,522,297   11,331,258   15,619,304   13,777,114 
                     
Common stock dividends on Preferred shares              238,167 
Total assets  11,838,003   12,621,803   12,610,740   15,732,149   16,077,947 
Long-term obligations (1)  2,825,633   3,960,874   3,819,946   3,678,663   3,665,730 
Shareholders’ equity  7,857,995   7,373,752   7,777,715   10,124,175   7,712,799 

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operation

The following discussion and analysis should be read in conjunction with the Company’s consolidated financial statements and the notes thereto presented elsewhere herein. The discussion of results should not be construed to imply any conclusion that such results will necessarily continue in the future.

Critical Accounting Policies

The Company’s significant accounting policies are described in Note 1 of the Consolidated Financial Statements that were prepared in accordance with accounting principles generally accepted in the United States of America. In preparing the Company’s financial statements, the Company made estimates and judgments that affect the results of its operations and the value of assets and liabilities the Company reports. The Company’s actual results may differ from these estimates.

The Company believes that the following summarizes critical accounting policies that require significant judgments and estimates in the preparation of the Company’s consolidated financial statements.

Revenue Recognition

The Company records revenue in accordance with Securitiesfrom the sale of its products and Exchange Commission Staff Accounting Bulletin No. 104, “Revenue Recognition” (“SAB 104”).  Under SAB 104, revenues are recordedservices when all four of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the sales price is fixed or determinable; and collectability is reasonably assured. Losses on contracts are recorded when identified.

Inventory

Inventories are stated at the lower of cost (first-in, first-out method) or market. Cost of manufactured goods includes material, labor and overhead.

The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

Goodwill and Intangible assets

Intangible assets with finite lives are amortized on a straight-line basis over the assets’ estimated useful life up to 14 years. The Company periodically evaluates on an annual basis, or more frequently when conditions require, whether events or circumstances have occurred indicating the carrying amount of intangible assets may not be recoverable. When factors indicate that intangible assets should be evaluated for possible impairment, the Company uses an estimate of the associated undiscounted future cash flows compared to the related carrying amount of assets to determine if an impairment loss should be recognized.

Goodwill and intangible assets not subject to amortization are tested in December of each year for impairment, or more frequently if events and circumstances indicate that the assets might have become impaired. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value.

Stock-based compensation

Stock based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value of restricted stock units granted is estimated based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

Income Taxes

Deferred income taxes are provided on the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

The Company recognizes the financial statement benefit of an uncertain tax position only after determining that the relevant tax authority would more likely than not sustain the position. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

The Company classifies interest and penalties related to income taxes as income tax expense in its Consolidated Financial Statements

10

Results of Operations

The following table summarizes the Company’s product sales by product categories during the past three years:

  Years Ended December 31, 
  2010  2009  2008 
Category Sales  %  Sales  %  Sales  % 
(In thousands) 
Optical Components $10,115   92  $10,350   94  $14,750   90 
Laser System Devices and Instrumentation  939   8   701   6   1,551   10 
TOTAL $11,054   100  $11,051   100  $16,301   100 

  Years Ended December 31, 
  2011  2010  2009 
Category Sales  %  Sales  %  Sales  % 
  (In thousands) 
Optical Components $11,812   90  $10,115   92  $10,350   94 
Laser System Devices and Instrumentation  1,365   10   939   8   701   6 
TOTAL $13,177   100  $11,054   100  $11,051   100 

The following table provides information on the Company’s sales to its major business sectors during the past three years:

Market  2010  2009  2008  
      (In thousands)    
Defense/Aerospace $6,968(63)% $7,454(68)% $10,329(63)%
Process control & metrology  2,751(25)%  2,339(21)%  4,692(29)%
Laser systems and other  796(7)%  766(7)%  1,077(7)%
Universities & national laboratories  539(5)%  492(4)%  203(1)%
Total $11,054(100)% $11,051(100)% $16,301(100)%

Market 2011  2010  2009 
  (In thousands) 
Defense/Aerospace $6,734   (51)% $6,968   (63)% $7,454   (68)%
Process control & metrology  4,752   (36)%  2,751   (25)%  2,339   (21)%
Laser systems and other  1,255   (10)%  796   (7)%  766   (7)%
Universities & national laboratories  436   (3)%  539   (5)%  492   (4)%
Total $13,177   (100)% $11,054   (100)% $11,051   (100)%

The following table sets forth, for the past three years, the percentage relationship of statement of operations categories to total revenues.

  Years ended December 31, 
  2010  2009  2008 
Revenues:         
Product sales  100.0%  100.0%  100.0%
Costs and expenses:            
Cost of goods sold  77.3%  80.5%  70.5%
Gross profit margin  22.7%  19.5%  29.5%
Selling, general and administrative expenses  28.1%  29.7%  23.7%
Goodwill impairment charge     14.1%   
(Loss) income from operations  (5.4) %  (24.3) %  5.9%
Net (loss) income  (6.6) %  (25.3) %  6.7%

  Years ended December 31, 
  2011  2010  2009 
Revenues:            
Product sales  100.0%  100.0%  100.0%
Costs and expenses:            
Cost of goods sold  73.0%  77.3%  80.5%
Gross profit margin  27.0%  22.7%  19.5%
Selling, general and administrative expenses  24.7%  28.1%  29.7%
Goodwill impairment charge        14.1%
Income (loss) from operations  2.3%  (5.4)%  (24.3)%
Net income (loss)  1.3%  (6.6)%  (25.3)%

Revenues

Total revenues were $13,177,000 in 2011, $11,054,000 in 2010 and $11,051,000 in 2009 and $16,301,000 in 2008 reflecting the consolidated results from all business units.operations. Revenues werein 2011 increased 19.2% compared to 2010, which follows two years for relatively unchanged revenues for 2010 and 2009. The increase in 20102011 is mainly due to an increase in orders from 2009, followingboth new and existing customers in the process control and metrology markets that we serve which was partially offset by a decrease of 32% in 2009 compared with 2008.  Overall, the Company’s sales in 2010 continued to reflect the reduced spending by the defense/aerospace customers we serve in the defense/aerospace customers. The net increase in revenues in 2011 is comprised of an increase of 16.8% in sales of optical components and the lingering effectsan increase of the economic recession on many45.4% in sales of our commercial customers that negatively affected the demand for the Company’s products that beganlaser system devices and instrumentation, both as compared to 2010.

Sales in 2009.

Sales to the Defense and Aerospace sectormarket declined by 3.4% to $6,734,000 in 2011 compared to $6,968,000 in 2010. Sales in 2010 also declined by 6.5% to $6,968,000 in 2010 compared to $7,454,000 in 2009 aswhich was also a decline of 27.8% compared to 2008. Although the rate of the declines are smaller, the Company continued to feel the impact ofthat the economic downturn has had on our customers spending patterns and due to changes in government defense spending foron products or systems supplied by our customers.  However, the decline was less than in 2009 in which sales in this sector fell by almost 27.8% from 2008.  Sales were $6,968,000 in 2010 compared to sales of $7,454,000 in 2009 and $10,329,000 in 2008.  Defensethey supply. For instance, defense spending on existing electro-optical systems over the last two fiscal periodsthree years has slowed, impacting the demand for the Company’s services in manufacturing custom products for its OEM customers.
11

Sales in the Process Control and Metrology market, sector, the Company’s second largest market, increased in 2011 by 72.7% to $4,752,000 compared to $2,751,000 in 2010. In 2010, sales increase by 17.6% to $2,751,000 compared to $2,339,000 in 2009. In addition, as a percentage of total sales, this sector increased to 36% compared to 25% in 2010 and 21% in 2009. The increase in sales was mainly the result of total sales.  This occurred asthe increasing sales demand many of our customers in this sector experienced anfor systems they sell containing our products. The increase in demand for their systems that contain the products that we supply to them.  In 2009, sales in this sector decreased both2011 and 2010, as a percentage of total sales and in relative sales dollars.  This reflectedcompared to 2009, reflect the severe impact of the economic downturn,recession, that year, which particularly in theaffected demand for our products by our commercial and semi-conductor markets and in particular, the customer base that the Company serves.  Sales were $2,339,000 or 21% of total sales compared to sales in 2008 of $4,692,000 or 29% of total sales.

customers.

The Company serves the non-military laser industry as an OEM supplier of standard and custom optical components and laser accessories. This sector’smarket’s sales increased to $539,000 from $193,000 fromin 2010 and $138,000 in 20092009. The increases over the past two year have principally come from increased demand in the medical laser industry but remained below sales in 2008 of $463,000.industry. The Company includes sales of other products that are not currently large enough to list individually, in this market segment. Sales of these other products have been in the $500,000 to $700,000 range historically and were $716,000 in 2011, $603,000 in 2010, and $628,000 in 2009 and $614,000 in 2008.2009. Overall, the market for laser systems and other products represented 10% of total sales in 2010 and 7% of total sales in 2010 and 2009, and 2008, respectively.

Sales to customers within the Universityuniversity and National Laboratoriesnational laboratories market sector increaseddecreased in 2011 to $436,000 or 3% of total sales compared with an increase in 2010 to $539,000 or 5% of total sales from $492,000 or 4% of total sales in 20092009. Although the results as demanda percentage of total sales vary slightly from year to year the total dollar amount remained relatively unchanged over the past three years and is dependent on research projects and the availability of funding for such projects.

Bookings

The Company booked new orders totaling $12.9 million in 2011, an increase from $12.3 million in 2010. The increase in 2011 was across all the business sectors that the Company serves and consisted of orders from the new customers and increases from most of our products serving this market increased slightly.

Bookings
Theexisting customer base. While the timing of the orders placed by customers may vary from quarter to quarter, the second half of the year was only slightly better.

In 2010, the Company booked new orders totaling $12.3 million in 2010, an increase from the $9.5 million in 2009 and comparable with $13.0 million in 2008.2009. The increase in 2010 was incurred across all the business sectors that the Company serves. However, a significant portion of the 2010 bookings were recorded in the second half of the year as the result of orders from the new customers and increases from most of our existing customer base.

In 2009, the Company booked new orders of $9.5 million compared with $13.0 million in 2008.  

The decrease in bookings from the prior year reflects a decline across all the business sectors that the Company serves.  Despite the decrease, the Company was able to add several new customers while maintaining most of its existing customer base.

In 2008, the Company booked new orders of $13.0 million   The Company had two large bookings near the end of 2007 which were scheduled to carry through 2008 and into 2009.  In the second half of 2008, MRC orders decreased as the impact of the economic downturn and defense sector slowdown affected our commercial customer’s and they experienced a slowdown in their business activities and demand for products.  This carried over into 2009.
As a result of the increase in bookings in 2010, the Company’s backlog as of December 31, 2010 increased2011 decreased to $4.9 million from $5.4 million compared to $4.4 million in 2009.as of December 31, 2010. The Company’s backlog as of December 31, 2009 was $4.4 million, down from $6.1 million at December 31, 2008.
million.

Cost of Goods Sold and Gross Profit Margin

Cost of goods sold as a percentage of sales was 77.3%73.0%, 80.5%77.3% and 70.5%80.5%, for the years ended December 31, 2011, 2010 2009 and 2008,2009, respectively. In dollar terms, 20102011 cost of goods sold was $9,615,000 increased from $8,545,000 which isin 2010 in conjunction with the increase in sales in 2011. Cost of goods sold in 2010 was down 3.9% from $8,897,000 in 2009 even though revenues remained unchanged.

The increase in cost of goods sold in 2011 compared to 2010 is primarily due to increases in material costs, manufacturing labor and operating costs. Compared to 2010, material costs increased by $591,000 principally due to product mix which had a higher material costs. In addition, the cost of manufacturing wages and salaries and related fringe benefits increased by $398,000 principally due to the increase in direct labor required to meet demand.

The slight decrease in cost of goods sold in 2010 compared to 2009 is primarily due to declines in labor and operating costs partially offset by an increase in material costs. Compared to last year,2009, total manufacturing wages and salaries decreased by $332,000 as operations continued to implement process improvements and resulted in a decrease in non-labor operating expenses of $184,000. Conversely, material costs increased by $213,000 for the Company which was mainly due to product mix at our Florida facility.

The increase in cost of goods sold percentage inpercentagein 2009 compared to 2008 is primarily due to the significant decline in sales volume during the year, net of cost reductions implemented by the Company during the year. Compared to the prior year, material cost as a percentage of sales remained unchanged from 2008 although in dollar terms material costs declined by $913,000, as expected with the lower sales volume levels. Total manufacturing wages and salaries declined by approximately $832,000 but rose by 5.6 percentage points, as a percentage of sales. Non-labor operating costs excluding depreciation also fell in dollar terms in 2009 by approximately $606,000 or 26.7% from 2008, but as a percentage of sales, increased by about 1.1 percentage points from the prior year.

Gross margin in 2011 was $3,562,000 or 27.0% which is an increase from 2010 wasgross margin of $2,509,000 or 22.7% which was an increase from 2009 gross margin of $2,154,000 or 19.5%. This compares with a gross margin of $4,815,000$2,154,000 or 29.5%19.5% in 2008.

2009.

Selling, General and Administrative Expenses

Selling, general and administrative expenses (“SSG&A”) were $3,255,000 in 2011, an increase of $150,000 or 4.8% from 2010. As a percentage of sales, SG&A expenses decreased to 24.7% of 2011 sales compared to 28.1% of sales in 2010. The decline in SG&A expenses, as a percentage of sales, reflects the impact of cost reductions in SG&A salaries and wages and fringe benefits from personnel reductions started in the second half of the prior year, offset by higher expenses related to the increase in sales in the current year.

SG&A expenses were $3,105,000 in 2010, down $174,000 or 5.3% from 2009. As a percentage of sales, SG&A expenses were 28.1% of 2010 sales compared to 29.7% of sales in 2009. The decline resulted mainly from reductions in SG&A salaries and wages and fringe benefits from personnel reductions in the second half of the year and continued cost management of other SG&A expenses throughout the year.

12

SG&A expenses were $3,278,000

Operating Income (Loss)

The Company had an operating income of $307,000 in 2009, down $580,000 or 15% from 2008, and as a percentage of sales represented 29.7% of sales in 2009 and 23.7% of sales in 2008. The decline in dollar expense resulted mainly from reductions in SG&A salaries and wages and fringe benefits reflecting personnel reductions implemented in2011 which was an improvement after the first quarter of 2009 and continued cost management throughoutlosses incurred during the year.  Overall, SG&A salary and wages decreased by 14.5% overpast two years. In 2010, the prior year.  Non-payroll SG&A expenses, excluding depreciation, also declined by 15.5% compared to 2008.

Operating (Loss) Income
The Company had an operating loss of $596,000 and in 2010 which was an improvement over the loss incurred during the prior year.  In 2009 the Company had an operating loss of $1,124,000 excluding a non-cash charge for the impairment of goodwill of $1,558,000, as discussed in Note 4 of the Company’s Consolidated Financial Statements.$1,558,000. The losses in 2010 and 2009, primarily, reflect thea significant decrease in sales as discussed above, compareddue to 2008 whenthe economic recession which severely impacted the Company had operating income of $957,000.
during this period.

Other Income and Expenses

Net interest expense of $130,000 in 2011 decreased 5.3% from $138,000 in 2010. Interest expense was $163,000 in 2011 compared to $164,000 in 2010which is the result of the Company’s normal scheduled debt repayments. Interest income for 2011 increased to $33,000 from $26,000 in 2010 mainly as a result of changes in short term cash balances and bank money market interest rates.

Net interest expense of $138,000 in 2010 increased 5.7% from $130,000 in 2009. Interest expense was $164,000 in 2010 compared to $167,000 in 2009 which2009which is the result of the Company’s normal scheduled debt repayments. Interest income for 2010 was $26,000 down from $38,000 in 2009 mainly as a result of reductions in bank interest rates on invested cash balances.

Net interest expense

In 2011, the Company sold surplus equipment and recorded a loss $1,003 on the sales.

Income Taxes

In 2011, the Company recorded a current provision for state tax and federal alternative minimum tax in the amount of $130,000 in 2009 declined 23.5% from $170,000 in 2008.  Interest expense was $167,000 in 2009 compared to $236,000 in 2008 which reflects the positive impact of the Company’s continued reduction in debt and long term notes.  Interest income for 2009 was $37,000 down from $66,000 in 2008 mainly as a result of reductions in bank interest rates on invested cash balances.

Income Taxes
$11,000. In 2010 and 2009, the Company did not record a current provision for either state tax or federal alternative minimum tax due to the losses incurred for both income tax and financial reporting purposes.
In 2008, the Company recorded a current provision for state tax and federal alternative minimum tax of $100,000 and $5,000, respectively, after the application of net operating losses of $523,000 against federal tax

The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

At December 31, 2010,2011, the Company had a net deferred tax asset balance of $2,787,000,$2,860,000, an increase of $271,000$73,000 from 2009.  Most of the increase relates primarily to the addition to the Company’s net operating loss carry forward position which resulteda $2,787,000 in 2010 and $344,000 from net operating losses$2,516,000 in 2010.  Although the Company believes that the current year’s losses were caused by the recessionary economic conditions that are improving, the Company has increased the valuation allowance to $2,379,000 to fully offset the current year’s increase in the deferred tax asset.

At December 31, 2009, the Company had a total net deferred tax asset balance of $2,516,000, an increase of $375,000 from 2008 primarily from the increase to the net operating loss carry forward position that resulted from the losses incurred in 2009.

As of December 31, 2011, 2010 and 2009, the Company recognized a portion of the net deferred tax assets in the amount of $408,000 which the Company’s management is reasonably assured will be fully utilized in future periods. Although the Company’s current year financial results were positively affected by the strengthening economy, primarily in the second half of the year, we increased the valuation allowance to $2,452,000 to fully offset the increase in the deferred tax asset. In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income that is consistent with the plans and estimates that management is using to manage the underlying business.

The Company’s valuation allowance as of December 31, 20102011 will be maintained until management concludes that it is more likely than not that the remaining deferred tax assets will be realized. When sufficient positive evidence exists, the Company’s income tax expense will be reduced by the decrease in its valuation allowance. An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.

During the year ended December 31, 2008, Company determined that based on its recent history of consistent earnings and future

Net Income (Loss)

In 2011, net income projections, a full valuation allowance was no longer required.  Accordingly, the Company reduced the valuation allowance and recognized a deferred tax benefit available from the Company’s net operating loss carry forward position of $408,000 based on the effective federal tax rate of 34%.  This resulted in the Company recording a net benefit from income taxes of $303,000 after offsetting the deferred tax benefit against the current tax provision of $105,000.  At December 31, 2008, the Company had a  net deferred tax asset balance of $2,141,000 offset by a valuation allowance of $1,733,000.

13

Net (Loss) Income
The Company had$165,000, compared to a net loss of $734,000 in 2010 improving fromprimarily as a net loss in 2009.  Despite comparableresult of higher sales levelsand the improvement can be attributed, in part, to continued improvements in manufacturing costs and SG&Apositive leveraging of higher sales on the Company’s relatively fixed cost reductions during 2010.structure. In 2009, the Company had a net loss of $2,800,000 which included a $1,558,000 non-cash charge for goodwill impairment. This compares with net income of $1,098,000 in 2008.  Both 2010 and 2009 results were impacted by the decline inreduced sales volumes during the recession and reducedthe negative impact on profit margins, compared to 2008, which was somewhat offset by manufacturing and SG&A cost reductions in both years.
2010 and 2009.

Liquidity and Capital Resources

A major

The Company’s primary source of cash in recent years has been from operating cash flows. Other sources of cash include proceeds received from the exercise of stock options short-term borrowing, and issuance of common stock. The Company’s major uses of cash in the past three years have been for capital expenditures and for repayment and servicing of outstanding debt.

debt and accrued interest.

Supplemental information pertaining to our source and use of cash is presented below:

Selected Sources (uses) of cash Years ended December 31, 
  2010  2009  2008 
  (In thousands) 
Net cash provided by operations $576  $815  $548 
Net Proceeds from issuance of common stock, exercise of stock options and warrants  7   162   1,064 
Capital Expenditures  (278)  (211)  (785)
Principal payments on lease obligations        (47)
Principal payments on debt obligations  (9)  (137)  (1,715)

Selected Sources (uses) of cash Years ended December 31, 
  2011  2010  2009 
  (In thousands) 
Net cash (used) provided by operations $(358) $576  $815 
             
Net Proceeds from issuance of common stock, exercise of stock options and warrants  18   7   162 
             
Capital Expenditures  (304)  (278)  (211)
             
Precious Metals  (318)     (37)
             
Principal payments on debt obligations  (9)  (9)  (137)

In 2011, the Company used cash to accelerate the payment of accrued interest of $1,125,000 on Related Party Convertible Notes Payable, as well as paying current interest on debt obligations, and financing capital expenditures. In 2010 and 2009, the Company primarily used excess cash to finance capital expenditures and repay outstanding debt.

In 2008, excess cash was used to retire a convertible promissory note in2011, proceeds from the amountexercise of $1,700,000, in addition to accelerating the repayment20,000 stock options and issuance of other notes payable and lease obligations, as well as, financing capital expenditures.  

6,239 common shares totaled $18,260. In 2010, proceeds from the exercise of 10,000 stock options and issuance of 5,906 common shares totaled $7,102. During 2009, 84,500 stock options were exercised for proceeds of $96,600$96,575 at a weighted exercise price of $1.14 per share and converted into an equivalent number of shares of the Company’s common stock.  Proceeds from the exercise of stock options were $285,000 in 2008, with 182,000 stock options exercised at a weighted average exercise price of approximately $1.42 per share.

During 2009, a total of 50,000 warrants issued pursuant to a 2004 private placement were exercised by warrant holders with a total exercise price of $67,500. Also in July 2009, 893,790 warrants with an exercise price of $1.35 expired unexercised. These warrants were originally issued as part of a private placement of common stock in 2004.

During 2008, 518,635 warrants from the private placement were exercised by warrant holders.  A total of 375,520 warrants with a total exercise price of $507,000 were surrendered to the Company in exchange for the issuance of 375,250 shares of the Company’s common stock.  An additional 142,385 placement agent warrants were exercised using a cashless feature available for these warrants, in exchange for 89,702 shares of the Company’s common stock.

In March 2011, the maturity dates of a $1,500,000 Subordinated Convertible Promissory Note to Clarex Limited (“Clarex”) and a $1,000,000 Subordinated Convertible Promissory Note to an affiliate of Clarex were extended to April 1, 2013. The remaining terms and conditions of the notes were unchanged. These notes were previously issued on April 1, 2009 and had a maturity date of April 1, 2011. The notes bear interest at 6%. Interest accrues yearly, is payable on maturity and unpaid interest along with principal may be converted into securities of the Company as follows: The notes are convertible in the aggregate into 1,500,000 Units and 1,000,000 Units, respectively, with each unit consisting of one share of common stock and one warrant. Each warrant allows the holder to acquire 0.75 shares of common stock at a price of $1.35 per share and have an expiration date of April 1, 2016. Clarex is a significant shareholder of the Company.

14

On March 30,

During 2011, the Company paid a total of $1,125,000 of accrued interest, of $180,000 and $120,000 on the $1,500,000 Note and the $1,000,000 Note, respectively.two notes. In addition, the Company also paid $22,500 and $15,000$150,000 of current interest relating toon the $1.5 million Note and $1 million Note, respectively, as thenotes in 2011. The Company intends to stay current with interest payments for amounts that would accrue against these notes in 2011 and going forward.notes. Therefore, the Company expects to make a payment of $37,500 each quarter in 20112012 and through the maturity date to satisfy the amounts of accrued interest each quarter.  

In May 2009, the Company repaid a Promissory Note prior to maturity, in the amount of $125,000 and accrued interest of $4,212, which represented the balance of a Note issued by the Company as part of the purchase price of MRC in 2004, to the sole shareholder of the acquired company.

On January 29, 2008, the Company repaid a $1,700,000 Secured Promissory Note held by a major shareholder, including accrued interest of $477,444.  The note was originally issued in June 2003 for a period of 18 months at an interest rate of 6% per annum and was secured by all assets of the Company.  As additional consideration for the note, the Company issued 200,000 warrants.
In March 2008, 200,000 warrants due to expire on March 31, 2008 were exercised and the Company issued 200,000 shares of its common stock for proceeds of $85,000.
In May 2008, an additional 200,000 warrants set to expire on May 18, 2008 were exercised for $216,000 and the Company issued 200,000 shares of its common stock.

In 2009, certificate of deposits totaling $800,000 were redeemed compared to an investment of $800,000 in certificates of deposit 2008.

In 2011, capital expenditures of $304,000 were primarily to replace or refurbish both operating facilities, purchase equipment upgrades to the computer information system and manufacturing equipment. In 2011, the company purchased additional manufacturing tools made from platinum at a net cost of $318,000 to further increase our crystal growth capacity at our Northvale, New Jersey facility.

The Company had capital expenditures in 2010 in the amount of $278,000, primarily to replace or refurbish manufacturing equipment and for additional equipment required to increase our crystal growth capacity at our Northvale, New Jersey location. For the year ended December 31, 2009 capital expenditures of $211,000 included planned expenditures primarily for manufacturing and optical testing equipment designed to increase production efficiency at our Northvale, New Jersey location. In addition, the Company purchased a manufacturing tool made from platinum at a net cost of $53,000. The cost was offset by proceeds from the sale of platinum for $16,000, as part of the purchase arrangement.

This compares

In 2011, cash decreased by $965,000 compared to capital expendituresan increase of $296,000 in 2008 of approximately $784,000.2010. In 2008, capital expenditures were primarily for increased production capacity and capability in both our Sarasota, Florida and Northvale, New Jersey locations.  Offsetting the impact of capital expenditures on2010, cash flows was the receipt of $10,000 from the sale of surplus manufacturing equipment during the second quarter of 2008.

Cash increased by $296,000 in 2010 compared to an increase of $597,000 for 2009 (including(excluding proceeds from the redemption of certificates of deposit). In  2008, cash decreased by $924,000 (including certificatesdeposit in the amount of deposit) reflecting lower cash provided from operations and used for capital expenditures and repayment of convertible debt.
$800,000).

A summary of the Company’s contractual cash obligations at December 31, 20102011 is as follows:

 
 
Contractual Obligations
 Total  
Less than
1 Year
  1-3 Years  
4-5
Years
  
Greater
Than 5
Years
 
  (In thousands) 
Convertible notes payable $2,500  $  $2,500  $  $ 
Accrued interest on related party convertible notes payable  1,125      1,125       
Notes payable-other, including interest  527   23   69   46   389 
Operating leases  1,015   480   535       
Total contractual cash obligations $5,167  $503  $4,229  $46  $389 

Contractual Obligations Total  Less than
1 Year
  1-3 Years  4-5
Years
  Greater
Than 5
Years
 
  (In thousands) 
Convertible notes payable $2,500  $  $2,500  $  $ 
Notes payable-other, including interest  503   23   69   46   365 
Operating leases  1,086   440   646       
Total contractual cash obligations $5,167  $503  $4,229  $46  $389 

Overview of Financial Condition

As shown in the accompanying financial statements, the Company reported a net lossincome of $734,000,$165,000 in 2011 compared to a net loss of $734,000 and $2,800,000 whichin 2010 and 2009, respectively. The net loss in 2009 included a non-cash charge for goodwill of $1,558,000$1,558,000. During 2011, the Company’s working capital requirements were provided by cash from operations and recorded net income of $1,098,000 in 2008.  Duringavailable cash balances. In 2010 2009 and 2008,2009, the Company’s working capital requirements were provided by positive cash flow from its operations.

Net

In 2011, net cash used by operations was $358,000 compared to net cash provided by operations wasof $576,000 in 2010, $815,000 in 2009, $548,000 in 2008.2010. The decrease in cash provided by operations was primarily the results of the net changes in working capital requirements in 2010, which resultsresulted from the payment of accrued interest on the Related Party Convertible Note Payable, an increase in accounts receivable and inventory (excluding reserves)reserve) during the year and a decrease in customer advances, offset by a decrease in accounts receivable and an increase in accounts payable and accrued liabilities and customer advances.liabilities. The Company’s management expects that future cash flow from operations and its existing cash reserves will provide adequate liquidity for the Company’s operations and working capital requirements in 2011.

15

2012.

Off-Balance Sheet Arrangements

The Company did not have any off-balance sheet arrangements at December 31, 20102011 and 2009.

2010.

Item 7A.Quantitative and Qualitative Disclosures about Market Risk
The Company believes that it has limited exposure to changes in interest rates from investments in certain money market accounts.  The Company does not utilize derivative instruments or other market risk sensitive instruments to manage exposure to interest rate changes.

N/A

Item 8.Financial Statements and Supplementary Data

The financial statements and supplementary financial information required to be filed under this Item are presented commencing on page 24 of the Annual Report on Form 10-K, and are incorporated herein by reference.

Item 9.Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

None

Item 9A.Controls and Procedures
a)  Evaluation of Disclosure Controls and Procedures

a)Evaluation of Disclosure Controls and Procedures

The Company’s management, including the Chief Executive Officer and the Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Annual Report on Form 10-K. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures as of December 31, 20102011 are effective to ensure that information required to be disclosed in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to the Company’sCompany's management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding disclosure.

b)  Management’s Annual Report on Internal Control over Financial Reporting

b)Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining an adequate system of internal control over financial reporting. Our internal control over financial reporting includes those policies and procedures that:

·pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

·provide reasonable assurance that transactions are recorded as necessary to permit preparation of our financial statements in accordance with generally accepted accounting principles in the United States, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

·provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

Our management assessed the effectiveness of our system of internal control over financial reporting as of December 31, 2010.2011. In making this assessment, management used the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our assessment and the criteria set forth by COSO, management has concluded that the Company maintained effective internal control over financial reporting as of December 31, 2010.

16

c)  Changes in Internal Control over Financial Reporting
2011.

c)Changes in Internal Control over Financial Reporting

There have been no significant changes in the Company’s internal control over financial reporting identified in connection with the evaluation that occurred during the Company’s last fiscal quarter that have materially affected, or that are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

Item 9BOther Information

None

17


PART III

Item 10.Directors and Executive Officers of the Registrant and Corporate Governance

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20112012 Annual Meeting of Stockholders.

Item 11.Executive Compensation

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20112012 Annual Meeting of Stockholders.

Item 12.Security Ownership of Certain Beneficial Owners and Management

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20112012 Annual Meeting of Stockholders.

Item 13.Certain Relationships and Related Transactions

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20112012 Annual Meeting of Stockholders.

Item 14.Principal AccountingAccountant Fees and Services

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20112012 Annual Meeting of Stockholders.

18

PART IV

Item 15.Exhibits and Financial Statement Schedules

(a) (1)   Financial Statements.

Reference is made to the Index to Financial Statements and Financial Statement Schedule commencing on Page 24.

(a) (2)   Financial Statement Schedule.

Reference is made to the Index to Financial Statements and Financial Statement Schedule on Page 24. All other schedules have been omitted because the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the Financial Statements or Notes thereto.

(a) (3)Exhibits.

Exhibit No. Description of Exhibit
 
3.1
 Restated Certificate of Incorporation of Photonics Products Group, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
3.2
 By-Laws of Photonic Products Group, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
3.3
 Certificate of Amendment to Restated Certificate of Incorporation of Photonics Products Group, Inc., dated June 2, 2010 (incorporated by reference to Exhibit 3.1 to the Company’sCompany's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 7, 2010).
3.4
Certificate of Amendment to Restated Certificate of Incorporation of Photonics Products Group, Inc., dated January 23, 2012 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on January 23, 2012).
4.1
 Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.2
Form of Warrants issued pursuant to June 2004 Private Placement (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.3
Form of Placement Agent Warrants issued pursuant to June 2004 Private Placement (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.4
 Promissory Note Dated June 30, 2003 held by Clarex, Ltd. (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.5
4.3
 Subordinated Convertible Promissory Note dated April 1, 2004 held by Clarex, Ltd. (incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.6
4.4
 Warrant dated March 31, 2004 issued to Clarex, Ltd. (incorporated by reference to Exhibit 10.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.7
4.5
 Warrant dated May 19, 2004 issued to Clarex, Ltd. (incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.8
4.6
 Subordinated Convertible Promissory Note dated April 1, 2009 held by Clarex, Ltd. (incorporated by reference to Exhibit 4.12 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2009)
4.9
4.7
 Subordinated Convertible Promissory Note dated April 1, 2009 held by Welland, Ltd.  (incorporated by reference to Exhibit 4.13 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2009)
4.10
4.8
 Subordinated Convertible Promissory Note dated April 1, 2011 held by Clarex, Ltd. (which will supersede document 4.10) (incorporated by reference to Exhibit 4.12 to the Company’s Annual Report on 10-K filed with the Securities and Exchange Commission on March 31, 2011)
4.11
4.9
 Subordinated Convertible Promissory Note dated April 1, 2011 held by Welland, Ltd. (which will supersede document 4.10)  (incorporated by reference to Exhibit 4.13 to the Company’s Annual Report on 10-K filed with the Securities and Exchange Commission on March 31, 2011)
10.1
 2000 Equity Compensation Program (incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
10.2
 2010 Equity Compensation Program (incorporated by reference to Exhibit B to the Company’s Proxy Statement for the 2010 Meeting of Stockholders filed with the Securities and Exchange Commission on April 30, 2010)
14.1
 Code of Ethics (incorporated by reference to Exhibit 14.1 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2006)
21.1
 List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2006)
23.1 Consent of Holtz Rubenstein Reminick LLP Independent Registered Public Accounting Firm
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
19

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 PHOTONIC PRODUCTS GROUP,IRAD OPTICS, INC.
   
 By:/s/ Joseph J. Rutherford 
  Joseph J. Rutherford
  Chief Executive Officer
  
 Dated: March 31, 201130, 2012

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature Title Date
     
/s/ Jan M. Winston 
Chairman of the Boardof Directors
 March 31, 201130, 2012
Jan M. Winston 
of Directors  
     
/s/ Luke P. LaValle, Jr. Director March 31, 201130, 2012
Luke P. LaValle, Jr.
/s/ Thomas H. LenaghDirectorMarch 31, 2011
Thomas H. Lenagh
    
     
/s/ Dennis G. Romano Director March 31, 201130, 2012
Dennis G. Romano
    
     
/s/ N.E. Rick Strandlund Director March 31, 201130, 2012
N.E. Rick Strandlund
    
     
/s/ Joseph J. Rutherford 
President, Chief Executive Officerand Director
 March 31, 201130, 2012
Joseph J. Rutherford 
and Director  
     
/s/ William J. Foote 
Chief Financial Officer, Secretary andTreasurer
 March 31, 201130, 2012
William J. Foote 
Treasurer  

21
20

PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC. AND SUBSIDIARIES


INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS


THREE YEARS ENDED DECEMBER 31, 2010


2011

CONTENTS


 Page
Page 
Report of Independent Registered Public Accounting Firm23
 22 
Consolidated balance sheetsBalance Sheets as of December 31, 20102011 and 2009201024
 23 
Consolidated statementsStatements of operationsOperations for each of the three years in the period ended December 31, 2010201125
 24 
Consolidated statementsStatements of shareholders’ equityShareholders’ Equity for each of the three years in the period ended December 31, 2010201126
 25 
Consolidated statementsStatements of cash flowsCash Flows for each of the three years in the period ended December 31, 2010201127
 26 
Notes to consolidated financial statements28-40
 27-40 
Schedule II – Valuation and Qualifying Accounts41
21


Report of Independent Registered Public Accounting Firm

Board of Directors and Shareholders

Photonic Products Group,

Inrad Optics, Inc. and Subsidiaries

Northvale, New Jersey


We have audited the accompanying consolidated balance sheets of Inrad Optics, Inc. (formerly known as Photonic Products Group, Inc.) and Subsidiaries as of December 31, 20102011 and 2009,2010, and the related consolidated statements of operations, shareholders’shareholders' equity and cash flows for each of the three years in the period ended December 31, 2010.2011. We have also audited the schedule listed in Item 15(a)(2) of this Form 10-K for the years ended December 31, 2011, 2010 2009 and 2008.2009. These consolidated financial statements and financial statement schedule are the responsibility of the Company’sCompany's management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.


We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’sCompany's internal control over financial reporting.  Accordingly, we express no such opinion. An audit includes examining on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as, evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.


In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Photonic Products Group,Inrad Optics, Inc. and Subsidiaries as of December 31, 20102011 and 2009,2010, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2010,2011, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.


/s/Holtz Rubenstein Reminick LLP


New York, New York

March 31, 2011

22

PHOTONIC PRODUCTS GROUP, INC30, 2012

INRAD OPTICS, INC. AND SUBSIDIARIES


CONSOLIDATED BALANCE SHEETS


  December 31, 
  2010  2009 
Assets      
Current assets:      
Cash and cash equivalents $4,365,045  $4,069,310 
Accounts receivable (after allowance for doubtful accounts of $15,000 in 2010 and 2009)  2,224,592   1,927,672 
Inventories, net  2,390,876   2,265,973 
Other current assets  119,243   164,081 
Total Current Assets  9,099,756   8,427,036 
Plant and equipment:        
Plant and equipment at cost  14,879,508   14,604,728 
Less: Accumulated depreciation and amortization  (12,876,163)  (12,016,247)
Total plant and equipment  2,003,345   2,588,481 
Precious Metals  157,443   157,443 
Deferred Income Taxes  408,000   408,000 
Goodwill  311,572   311,572 
Intangible Assets, net of accumulated amortization  594,452   673,016 
Other Assets  47,235   45,192 
Total Assets $12,621,803  $12,610,740 
Liabilities and Shareholders’ Equity        
Current Liabilities:        
Current portion of notes payable -other $9,000  $9,000 
Accounts payable and accrued liabilities  836,190   657,650 
Customer advances  441,987   346,429 
Total Current Liabilities  1,287,177   1,013,079 
Related Party Convertible Notes Payable  2,500,000   2,500,000 
Accrued Interest on Related Party Convertible Note Payable  1,125,000   975,000 
Notes Payable – Other, net of current portion  335,874   344,946 
Total Liabilities  5,248,051   4,833,025 
Commitments        
Shareholders’ equity:        
Common stock: $.01 par value; 60,000,000 authorized shares 11,562,656 issued at December 31, 2010 and 11,443,347 issued at December 31, 2009  115,626   114,433 
Capital in excess of par value  17,402,528   17,073,871 
Accumulated deficit  (10,129,452)  (9,395,639)
   7,388,702   7,792,665 
Less - Common stock in treasury, at cost (4,600 shares)  (14,950)  (14,950)
Total Shareholders’ Equity  7,373,752   7,777,715 
Total Liabilities and Shareholders’ Equity $12,621,803  $12,610,740 

  December 31, 
  2011  2010 
Assets        
Current assets:        
Cash and cash equivalents $3,400,205  $4,365,045 
Accounts receivable (net of allowance for doubtful accounts of $15,000 in 2011 and 2010)  2,052,887   2,224,592 
Inventories, net  2,909,520   2,390,876 
Other current assets  185,298   119,243 
Total Current Assets  8,547,910   9,099,756 
Plant and equipment:        
Plant and equipment at cost  15,172,428   14,879,508 
Less: Accumulated depreciation and amortization  (13,629,311)  (12,876,163)
Total plant and equipment  1,543,117   2,003,345 
Precious Metals  474,960   157,443 
Deferred Income Taxes  408,000   408,000 
Goodwill  311,572   311,572 
Intangible Assets, net of accumulated amortization  515,888   594,452 
Other Assets  36,556   47,235 
Total Assets $11,838,003  $12,621,803 
         
Liabilities and Shareholders’ Equity        
Current Liabilities:        
Current portion of notes payable -other $9,800  $9,000 
Accounts payable and accrued liabilities  877,757   836,190 
Customer advances  266,818   441,987 
Total Current Liabilities  1,154,375   1,287,177 
         
Related Party Convertible Notes Payable  2,500,000   2,500,000 
Accrued Interest on Related Party Convertible Note Payable     1,125,000 
Notes Payable – Other, net of current portion  325,633   335,874 
Total Liabilities  3,980,008   5,248,051 
         
Commitments        
         
Shareholders’ equity:        
Common stock: $.01 par value; 60,000,000 authorized shares 11,713,564 issued at December 31, 2011 and 11,562,656 issued at December 31, 2010  117,137   115,626 
Capital in excess of par value  17,720,514   17,402,528 
Accumulated deficit  (9,964,706)  (10,129,452)
   7,872,945   7,388,702 
         
Less - Common stock in treasury, at cost (4,600 shares)  (14,950)  (14,950)
Total Shareholders’ Equity  7,857,995   7,373,752 
Total Liabilities and Shareholders’ Equity $11,838,003  $12,621,803 

See notes to consolidated financial statements

23

PHOTONIC PRODUCTS GROUP, INC

INRAD OPTICS, INC. AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF OPERATIONS


  Years Ended December 31, 
  2010  2009  2008 
Revenues         
Net sales $11,054,178  $11,051,127  $16,301,209 
Cost and expenses            
Cost of goods sold  8,545,153   8,896,539   11,486,620 
Selling, general and administrative expense  3,105,063   3,278,161   3,857,805 
Goodwill Impairment     1,558,074    
   11,650,216   13,732,774   15,344,425 
Operating (loss) income  (596,038)  (2,681,647)  956,784 
Other income (expense)            
Interest expense, net  (137,775)  (130,387)  (170,476)
Gain on sale of plant and equipment     4,671   9,113 
Gain on sale of precious metals     7,371    
   (137,775)  (118,345)  (161,363)
(Loss) income before income taxes  (733,813)  (2,799,992)  795,421 
Income tax benefit (provision)        303,000 
Net (loss) income $(733,813) $(2,799,992) $1,098,421 
Net (loss) income per share - basic $(0.06) $(0.25) $0.10 
Net (loss) income per share - diluted $(0.06) $(0.25) $0.08 
Weighted average shares outstanding - basic  11,522,297   11,331,258   10,902,061 
Weighted average shares outstanding – diluted  11,522,297   11,331,258   15,619,304 

  Years Ended December 31, 
  2011  2010  2009 
Revenues            
Net sales $13,177,194  $11,054,178  $11,051,127 
             
Cost and expenses            
Cost of goods sold  9,614,875   8,545,153   8,896,539 
Selling, general and administrative expense  3,255,073   3,105,063   3,278,161 
Goodwill Impairment        1,558,074 
   12,869,948   11,650,216   13,732,774 
             
Operating (loss) income  307,246   (596,038)  (2,681,647)
             
Other (expense) income            
Interest expense, net  (130,497)  (137,775)  (130,387)
(Loss) gain on sale of plant and equipment  (1,003)     4,671 
Gain on sale of precious metals        7,371 
   (131,500)  (137,775)  (118,345)
             
Income (loss) before income taxes  175,746   (733,813)  (2,799,992)
             
Income tax provision  11,000       
             
Net income (loss) $164,746  $(733,813) $(2,799,992)
             
Net income (loss) per share - basic $0.01  $(0.06) $(0.25)
             
Net income (loss) per share - diluted $0.01  $(0.06) $(0.25)
             
Weighted average shares outstanding - basic  11,658,891   11,522,297   11,331,258 
             
Weighted average shares outstanding – diluted  11,753,669   11,522,297   11,331,258 

See notes to consolidated financial statements


24


PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC. AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

        Capital in        Total 
  Common Stock  excess of     Treasury  Shareholders’ 
  Shares  Amount  par value  Deficit  Stock  Equity 
Balance, January 1, 2008  10,104,719  $101,046  $15,320,771  $(7,694,068) $(14,950) $7,712,799 
401K contribution  75,907   759   159,422         160,181 
Common stock issued on exercise of options  185,100   1,851   254,919         256,770 
Common stock issued on conversion of warrants  864,952   8,650   798,937         807,587 
Stock-based compensation expense        88,417         88,417 
Net income for the year           1,098,421      1,098,421 
Balance, December 31, 2008  11,230,678   112,306   16,622,466   (6,595,647)  (14,950)  10,124,175 
401K contribution  66,469   664   178,404         179,068 
Common stock issued on exercise of options  84,500   845   95,730         96,575 
Common stock issued on conversion of warrants  50,000   500   67,000         67,500 
Common stock issued on vesting of stock grants  11,700   118   (2,679)        (2,561)
Stock-based compensation expense        112,950         112,950 
Net loss for the year           (2,799,992)     (2,799,992)
Balance, December 31, 2009  11,443,347   114,433   17,073,871   (9,395,639)  (14,950)  7,777,715 
401K contribution  103,403   1,034   153,501         154,535 
Common stock issued on exercise of options  10,000   100   8,400         8,500 
Common stock issued on vesting of stock grants  5,906   59   (1,298)        (1,239)
Stock-based compensation expense        168,054         168,054 
Net loss for the year           (733,813)     (733,813)
Balance, December 31, 2010  11,562,656  $115,626  $17,402,528  $(10,129,452) $(14,950) $7,373,752 

        Capital in        Total 
  Common Stock  excess of  Accumulated  Treasury  Shareholders’ 
  Shares  Amount  par value  Deficit  Stock  Equity 
Balance, January 1, 2009  11,230,678  $112,306  $16,622,466  $(6,595,647) $(14,950) $10,124,175 
                         
401K contribution  66,469   664   178,404         179,068 
                         
Common stock issued on exercise of options  84,500   845   95,730         96,575 
                         
Common stock issued on conversion of warrants  50,000   500   67,000         67,500 
                         
Common stock issued on vesting of stock grants  11,700   118   (2,679)        (2,561)
                         
Stock-based compensation expense        112,950         112,950 
                         
Net loss for the year           (2,799,992)     (2,799,992)
                         
Balance, December 31, 2009  11,443,347   114,433   17,073,871   (9,395,639)  (14,950)  7,777,715 
                         
401K contribution  103,403   1,034   153,501         154,535 
                         
Common stock issued on exercise of options  10,000   100   8,400         8,500 
                         
Common stock issued on vesting of stock grants  5,906   59   (1,298)        (1,239)
                         
Stock-based compensation expense        168,054         168,054 
                         
Net loss for the year           (733,813)     (733,813)
                         
Balance, December 31, 2010  11,562,656   115,626   17,402,528   (10,129,452)  (14,950)  7,373,752 
                         
401K contribution  124,669   1,249   128,749         129,998 
                         
Common stock issued on exercise of options  20,000   200   18,800         19,000 
                         
Common stock issued on vesting of stock grants  6,239   62   (802)        (740)
                         
Stock-based compensation expense        171,239         171,239 
                         
Net income for the year           164,746      164,746 
                         
Balance, December 31, 2011  11,713,564  $117,137  $17,720,514  $(9,964,706) $(14,950) $7,857,995 

See notes to consolidated financial statements


25


PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF CASH FLOWS


  Years Ended December 31, 
  2010  2009  2008
Cash flows from operating activities:        
Net (loss) income $(733,813) $(2,799,992) $1,098,421 
Adjustments to reconcile net (loss) income to net cash provided by operating activities:            
Depreciation and amortization  941,941   1,008,310   1,059,741 
Goodwill impairment charge     1,558,074    
401K common stock contribution  154,535   179,068   160,180 
Accrued interest on Related Party Convertible Note Payable  150,000   150,000   150,000 
Deferred income taxes        (408,000)
Gain on sale of plant and equipment     (4,671)  (9,113)
Gain on sale of precious metal     (7,371)   
Stock-based compensation expense  168,054   112,950   88,417 
Change in inventory reserve  (154,326)  94,628   302,511 
Changes in operating assets and liabilities:            
Accounts receivable  (296,920)  882,930   (628,743)
Inventories  29,423   371,735   (103,767)
Other current assets  44,838   24,003   (24,019)
Other assets  (2,043)  34,107   7,865 
Accounts payable and accrued liabilities  178,540   (678,015)  (731,301)
Customer advances  95,558   (110,325)  (413,796)
Total adjustments  1,309,600   3,615,423   (550,025)
Net cash provided by operating activities  575,787   815,431   548,396 
Cash flows from investing activities:            
Proceeds (purchase) of certificates of deposit     800,000   (800,000)
Purchase of plant and equipment  (278,241)  (210,563)  (784,534)
Purchase of precious metals     (53,538)   
Proceeds from disposal of plant and equipment     4,671   10,000 
Proceeds from disposal of precious metals     16,317    
Net cash (used in) provided by investing activities  (278,241)  556,887   (1,574,534)
Cash flows from financing activities:            
Net proceeds from issuance of common stock  7,261   161,514   1,064,357 
Principal payments of notes payable-other  (9,072)  (136,609)  (14,989)
Principal payments of convertible promissory notes        (1,700,000)
Principal payments of capital lease obligations        (47,088)
Net cash (used in) provided by financing activities  (1,811)  24,905   (697,720)
Net increase (decrease) in cash and cash equivalents  295,735   1,397,223   (1,723,859)
Cash and cash equivalents at beginning of the year  4,069,310   2,672,087   4,395,945 
Cash and cash equivalents at end of the year $4,365,045  $4,069,310  $2,672,087 
Supplemental Disclosure of Cash Flow Information:            
Interest paid $14,000  $19,000  $508,000 
Income taxes (refund) paid $(74,000) $(8,000) $408,000 

  Years Ended December 31, 
  2011  2010  2009 
Cash flows from operating activities:            
             
Net income (loss) $164,746  $(733,813) $(2,799,992)
             
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:            
Depreciation and amortization  835,788   941,941   1,008,310 
Goodwill impairment charge        1,558,074 
401K common stock contribution  129,998   154,535   179,068 
Accrued interest on Related Party Convertible Note Payable     150,000   150,000 
Loss (gain) on sale of plant and equipment  1,003      (4,671)
(Gain) on sale of precious metals        (7,371)
Stock-based compensation expense  171,239   168,054   112,950 
Change in inventory reserve  55,174   (154,326)  94,628 
             
Changes in operating assets and liabilities:            
Accounts receivable  171,705   (296,920)  882,930 
Inventories  (573,818)  29,423   371,735 
Other current assets  (66,055)  44,838   24,003 
Other assets  10,679   (2,043)  34,107 
Accounts payable and accrued liabilities  41,567   178,540   (678,015)
Customer advances  (175,169)  95,558   (110,325)
Accrued interest on Related Party Convertible Note Payable  (1,125,000)      
Total adjustments  (522,889)  1,309,600   3,615,423 
Net cash (used in) provided by operating activities  (358,143)  575,787   815,431 
             
Cash flows from investing activities:            
Proceeds from sale of certificates of deposit        800,000 
Purchase of plant and equipment  (303,999)  (278,241)  (210,563)
Purchase of precious metals  (317,517)     (53,538)
Proceeds from disposal of plant and equipment  6,000      4,671 
Proceeds from disposal of precious metals        16,317 
Net cash (used in) provided by investing activities  (615,516)  (278,241)  556,887 
             
Cash flows from financing activities:            
Net proceeds from issuance of common stock  18,260   7,261   161,514 
Principal payments of notes payable-other  (9,441)  (9,072)  (136,609)
Net cash provided by (used in) financing activities  8,819   (1,811)  24,905 
             
Net (decrease) increase in cash and cash equivalents  (964,840)  295,735   1,397,223 
             
Cash and cash equivalents at beginning of the year  4,365,045   4,069,310   2,672,087 
             
Cash and cash equivalents at end of the year $3,400,205  $4,365,045  $4,069,310 
             
Supplemental Disclosure of Cash Flow Information:            
Interest paid $1,289,000  $14,000  $19,000 
Income taxes (refund) paid $18,000  $(74,000) $(8,000)

See notes to consolidated financial statements

26


PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC. AND SUBSIDIARIES


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


THREE YEARS ENDED DECEMBER 31, 2010

2011

1.Nature of Business and Operations and Summary of Significant Accounting Policies and Estimates

a.Nature of Business and Operations
Photonic Products Group,

Inrad Optics, Inc. and Subsidiaries (the “Company”), formerly known as Photonic Products Group, Inc., was incorporated in the state of New Jersey and is a manufacturer of crystals, crystal devices, electro-optic and optical components, and sophisticated laser subsystems and instruments. The Company has manufacturing operations in Northvale, New Jersey and Sarasota, Florida. Its principal customers include commercial instrumentation companies and OEM laser manufacturers, research laboratories, government agencies, and defense contractors. The Company’s products are sold domestically using its own sales staff, and in major overseas markets, principally Europe and Japan, and Asia, using independent sales agents.

b.Principles of consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Upon consolidation, all inter-company accounts and transactions are eliminated.

c.Use of estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from these estimates.

d.Cash and cash equivalents

The Company considers cash-on-hand and highly liquid investments with original maturity dates of three months or less at the date of purchase to be cash and cash equivalents. Investments with original maturity dates exceeding three months are separately disclosed on the Consolidated Balance Sheets and as cash flows from investing activities on the Consolidated Statements of Cash Flows.

e.Accounts receivable

Accounts receivable are carried at net realizable value, net of write-offs and allowances. The Company establishes an allowance for doubtful accounts based on estimates as to the collectability of accounts receivable. Management specifically analyzes past-due accounts receivable balances and, additionally, considers bad debt history, customer credit-worthiness, current economic trends and changes in customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. Uncollectible accounts receivable are written-off when it is determined that the balance will not be collected.

f.Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or market. Cost of manufactured goods includes material, labor and overhead.

The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

g.Plant and Equipment

Plant and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets which range between 5 and 7 years. Amortization of leasehold improvements is computed using the straight-line method over the lesser of 10 years or the remaining term of the lease including optional renewal periods, as appropriate, when failure to renew the lease imposes an economic penalty on the Company in such an amount that renewal appears to be probable. In determining the amount of the economic penalty, management considers such factors as (i) the costs associated with the physical relocation of the offices, manufacturing facility and equipment, (ii) the economic risks associated with business interruption and potential customer loss during relocation and transition to new premises (iii) the significant costs of leasehold improvements required at any new location to custom fit our specific manufacturing requirements, and (iv) the economic loss associated with abandonment of existing leasehold improvements or other assets whose value would be impaired by vacating the facility.

27

Maintenance and repairs of property and equipment are charged to operations and major improvements are capitalized. Upon retirement, sale or other disposition of property and equipment, the cost and accumulated depreciation are eliminated from the accounts and a gain or loss is recorded.

h.Income taxes

Deferred taxes are provided on the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

The Company recognizes the financial statement benefit of an uncertain tax position only after determining that the relevant tax authority would more likely than not sustain the position. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 % likelihood of being realized upon ultimate settlement with the relevant tax authority.


The Company classifies interest and penalties related to income taxes as income tax expense in its Consolidated Financial Statements.

The Company had no unrecognized tax benefits or liabilities, and no adjustment to its financial position, results of operations, or cash flows relating to uncertain tax positions taken on all open tax years. The Company is no longer subject to federal, state or local income tax examinations by tax authorities for the years before 2008.

i.Impairment of long-lived assets

Long-lived assets, such as plant and equipment and purchased intangibles with finite lives, which are subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimateestimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Long-lived assets held for sale would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and would no longer be depreciated.

j.Goodwill and intangible assets with indefinite lives

Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable assets of business acquisitions. Goodwill and intangible assets with indefinite lives are not amortized. The Company tests for impairment of goodwill and intangible assets with indefinite lives on an annual basis in December of each year, or more frequently whenever events occur or circumstances exist that indicates that impairment may exist.

k.
k.
Stock-based compensation

Stock based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value of restricted stock units granted is estimated based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

l.Revenue recognition

The Company records revenue from the sale of products and services used in the photonics industry when all four of the following criteria are met:

·persuasive evidence of an arrangement exists;

·delivery has occurred or services have been rendered;

·the sales price is fixed or determinable; and

·Collectability is reasonably assured.

Losses on contracts in progress are recorded when identified.

m.Internal research and development costs

Internal research and development costs are charged to expense as incurred.

28

n.Precious metals

Precious metals consist of various fixtures used in the high temperature crystal growth manufacturing process. They are valued at the lower of cost or net realizable value, on a first-in, first-out basis.

value.

o.Advertising costs

Advertising costs included in selling, general and administrative expenses were $16,000, $29,000 $32,000 and $26,000$32,000 for the years ended December 31, 2011, 2010 2009 and 2008,2009, respectively. Advertising costs are charged to expense when the related services are incurred or related events take place.

p.Statement of cash flows and non-cash transactions

For purposes of the consolidated statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months, or less when purchased, to be cash equivalents.

q.Concentrations and credit risk

The Company may invest its excess cash in certificates of deposits with major financial institutions. Generally, the investments range over a variety of maturity dates usually, within three to nine months, and therefore, are subject to little risk. The Company has not experienced losses related to these investments.

The concentration of credit risk in the Company’s accounts receivable is mitigated by the Company’s credit evaluation process, familiarity with its small base of recurring customers and reasonably short collection terms and the geographical dispersion of revenue. The Company generally does not require collateral but, in some cases, the Company negotiates cash advances prior to the undertaking of the work. These cash advances are recorded as current liabilities on the balance sheet until corresponding revenues are realized.

The Company utilizes many relatively uncommon materials and compounds to manufacture its products and relies on outside vendors for certain manufacturing services. Therefore, any failure by its suppliers to deliver materials of an adequate quality and quantity could have an adverse effect on the Company’s ability to meet the commitments of its customers.

For the year ended December 31, 2010,2011, the Company’s top five customer accounts in the aggregate represented approximately 53%58% of total revenues, and the top three customers accounted for 37%47% of revenues. These three customers each represented approximately 15%21%, 11%15% and 10%11% of sales, respectively. Since the Company is a supplier of custom manufactured components to OEM customers, the relative size and identity of the largest customer accounts changes somewhat from year to year. In the short term, the loss of any one of these large customer accounts could have a material adverse effect on business, results of operations, and financial condition.

r.Fair value measurements
Effective January 1, 2008, the

The Company adopted newfollows U.S. GAAP accounting guidance for all financial assets and liabilities and for non-financial assets and liabilities that are recognized or disclosed in the financial statements at fair value on a recurring basis. Additionally, effective January 1, 2009, the Company adopted new accounting guidance for non-financial assets and liabilities that are recognized or disclosed in the financial statements at fair value on a non-recurring basis. Although such adoption did not have a material impact on the Company’s Consolidated Financial Statements for 2009 or 2008, the pronouncement may impact the Company’s accounting for future business combinations, impairment charges and restructuring charges.

This new accounting guidance establishedwhich establishes a framework for measuring fair value and expanded related disclosures. The framework requires fair value to be determined based on the exchange price that would be received for an asset, or paid to transfer a liability (an exit price), in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants.

The valuation techniques required are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. The accounting guidance requires the following fair value hierarchy:

·Level 1 - Quoted prices (unadjusted) for identical assets and liabilities in active markets that the Company has the ability to access at the measurement date.

·Level 2 - Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.

·Level 3 - Values determined by models, significant inputs to which are unobservable and are primarily based on internally derived assumptions regarding the timing and amount of expected cash flows.
29

Long-lived assets, including goodwill and other intangible assets, may be measured at fair value if such assets are held for sale or if there is a determination that the asset is impaired. Managements’ determination of fair value, although highly subjective, is based on the best information available, including internal projections of future earnings and cash flows discounted at an appropriate interest rate, quoted market prices when available, market prices for similar assets, broker quotes and independent appraisals, as appropriate.

s.New Accounting Guidance

In January 2010,May 2011, the FASBFinancial Accounting Standards Board (“FASB”) issued guidanceAccounting Standards Update (“ASU”) No. 2011-04, “Amendments to amend the disclosure requirements relatedAchieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (“IFRS”).” This pronouncement was issued to recurring and nonrecurringprovide a consistent definition of fair value measurements.  The guidance requires new disclosures on the transfers of assets and liabilities between Level 1 (quoted prices in active market for identical assets or liabilities) and Level 2 (significant other observable inputs) ofensure that the fair value measurement hierarchy, including the reasons and timing of the transfers.  Additionally, the guidance requires a roll forward of activities on purchases, sales, issuancedisclosure requirements are similar between U.S. GAAP and settlements of the assets and liabilities measured using Level 3IFRS. ASU 2011-04 changes certain fair value measurements (significant observable inputs).  This guidance is effective for the Company on or after January 1, 2010, except formeasurement principles and enhances the disclosure on the roll forward activitiesrequirements particularly for Level 3 fair value measurements,measurements. This pronouncement is effective for reporting periods beginning on or after December 15, 2011, with early adoption prohibited. The new guidance will require prospective application. The Company expects that the adoption will not have a significant impact on its Consolidated Financial Statements.

In June 2011, the FASB issued ASU No. 2011-05, “Presentation of Comprehensive Income” which doeswas issued to enhance comparability between entities that report under U.S. GAAP and IFRS, and to provide a more consistent method of presenting non-owner transactions that affect an entity’s equity. ASU 2011-05 eliminates the option to report other comprehensive income and its components in the statement of changes in stockholders’ equity and requires an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement or in two separate but consecutive statements. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and full retrospective application is required. The Company expects that the adoption will not becomehave a significant impact on its Consolidated Financial Statements.

In September 2011, the FASB issued Accounting Standards Update (“ASU”) No. 2011-08, Intangibles-Goodwill and Other – Testing Goodwill for Impairment (“ASU No. 2011-08”). ASU No. 2011-08 permits an entity to make a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before automatically applying the two-step goodwill impairment test, which has been the required test since 2002. If an entity determines that this is the case, it is necessary to perform the currently prescribed two-step goodwill impairment test to determine the amount, if any, of impaired goodwill. Otherwise, the two-step goodwill impairment test is not required. This new guidance is effective untilfor annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2010.  Adoption2011 with early adoption permitted. The Company has not elected early adoption and expects that the adoption of thisthe new guidance is for disclosure purposes only and didstandard will not have a material effect on our consolidated financial position, results of operations or cash flows.

In April 2010, the Financial Accounting Standards Board (FASB) ratified a consensus of the FASB Emerging Issues Task Force that recognizes the milestone method as an acceptable revenue recognition method for substantive milestones in research or development arrangements.  This consensus requires its provisions be met in order for an entity to recognize consideration that is contingent upon achievement of a substantive milestone as revenue in its entirety in the period in which the milestone is achieved.  In addition, this consensus would require disclosure of certain information with respect to arrangements that contain milestones.  This authoritative was adopted by the Company on July 1, 2010 but did not have a materialsignificant impact on our consolidated financial statements.
The Company reviewed events for inclusion in the consolidated financial statements through the filing date of its financial statements.
Consolidated Financial Statements.

2.Inventories, net

Inventories are comprised of the following and are shown net of inventory reserves of $1,310,000 for 2011 and $1,255,000 for 2010 and $1,410,000 for 2009:

  December 31, 
  2010  2009 
   (In thousands) 
Raw materials $1,103  $1,066 
Work in process, including manufactured parts and components  806   654 
Finished goods  482   546 
  $2,391  $2,266 
2010:

  December 31, 
  2011  2010 
  (In thousands) 
Raw materials $1,072  $1,103 
Work in process, including manufactured parts and components  984   806 
Finished goods  854   482 
  $2,910  $2,391 

3.Plant and Equipment

Plant and equipment are comprised of the following:


  December 31, 
  2010  2009 
  (In thousands) 
Office and computer equipment $1,339  $1,330 
Machinery and equipment  11,436   11,230 
Leasehold improvements  2,104   2,044 
   14,879   14,604 
Less accumulated depreciation and amortization  (12,876)  (12,016)
  $2,003  $2,588 

  December 31, 
  2011  2010 
  (In thousands) 
Office and computer equipment $1,461  $1,339 
Machinery and equipment  11,514   11,436 
Leasehold improvements  2,197   2,104 
   15,172   14,879 
Less accumulated depreciation and amortization  (13,629)  (12,876)
  $1,543  $2,003 

Depreciation expense recorded by the Company totaled $757,000, $863,000 and $929,000 for 2011, 2010 and $981,000 for 2010, 2009, and 2008, respectively. Plant and equipment with a net book value of $7,003, $944 $0 and $887$0 was disposed of in 2011, 2010 and 2009, respectively.

The Company evaluates its property and 2008, respectively.

30

4.Goodwill
The following table summarizes goodwill balancesequipment and intangible assets with finite lives for impairment when events or circumstances indicate and impairment may exist. Management concluded that an impairment of its long-lived assets was not required at December 31, 20102011 and 2009 and changes in theDecember 31, 2010.

4.Goodwill

The carrying amountvalue of goodwill during the years then ended:

   
Amount
(In thousands)
 
Balance at December 31, 2008  $1,870 
Impairment charge in 2009   (1,558)
Balance at December 31, 2009
 
`
 $312 
Balance at December 31, 2010  $312 
was $312,000 at December 31, 2011 and 2010.

The Company tests for impairment of goodwill in December of each year. The testing for goodwill impairment is a two-step process. The first step compares the fair value of each reporting unit to its carrying value. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired as of the measurement date. Otherwise, if the carrying value exceeds the fair value, a second step must be followed to determine the level of impairment. In establishing the fair value of the reporting unit, the Company uses both a market based approach and an income based approach as part of its valuation methodology. Since quoted market prices in an active market are not separately available for the Company’s reporting units, the market based method estimates the fair value of the reporting unit utilizing an industry multiple of projected earnings before interest taxes, depreciation and amortization (“EBITDA”). Due to the small capitalization value of the Company, the low trading volume of its stock and the niche market served by its products, the application of available industry comparables in establishing fair value requires a high degree of management judgment, and the actual fair value that could be realized could differ from those used to evaluate the impairment of goodwill. The income approach determines fair value based on the estimated discounted cash flows that each reporting unit is expected to generate in the future. For each method, the sensitivity of key assumptions are tested by using a range of estimates and the results of each method are corroborated as part of management’s determination of fair value.

The second step of the testing process, if necessary, involves calculating the fair value of the individual assets and liabilities of the reporting unit and measuring the implied fair value of the goodwill against its carrying value to determine whether an adjustment to the carrying value of goodwill is required. This process also has inherent risks and uncertainties and requires significant management judgment.

Based on the results of the tests performed, management concluded that there is no impairment of goodwill at December 31, 2010.

During 2009, the Company experienced declines in sales and profitability, and economic and industry conditions remained uncertain.  In the third quarter of 2009, the Company tested for impairment of goodwill for its two reporting units which the Company has identified as its two geographical operating units in Florida and New Jersey. In making this assessment, management considered a number of factors which included, among others, historical and current operating results and cash flows, then current projections of future financial results and cash flows, business plans, current and projected economic conditions and industry trends.
Upon completion of the first step, the Company concluded that the carrying value of its Florida reporting unit exceeded its fair value and a step two analysis was required.  The step-two analysis resulted in the Company recording an impairment charge against the full carrying value of goodwill of its Florida reporting unit, in the amount of $1,558,074. The Company also determined that the carrying value of its goodwill in connection with its acquisition of its New Jersey reporting unit in the amount of $312,572 was not impaired as of December 31, 2009.
The Company also evaluates its property and equipment and intangible assets with finite lives for impairment when events or circumstances indicate and impairment may exist.  Management concluded that an impairment of its long-lived assets was not required at December 31, 2010 and December 31, 2009.
2011.

5.
Intangible Assets

Intangible assets include acquired intangible assets with finite lives, consisting principally of non-contractual customer relationships, completed technology and trademarks. Intangible assets with finite lives are amortized on a straight-line basis over the assets’ estimated useful life up to 14 years. The Company evaluates whether events or circumstances have occurred indicating the carrying amount of intangible assets may not be recoverable. When factors indicate that intangible assets should be evaluated for possible impairment, the Company uses an estimate of the associated undiscounted future cash flows compared to the related carrying amount of assets to determine if an impairment loss should be recognized. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value.

31

Amortization expense was approximately $79,000 for the years ended December 31, 20102011 and December 31, 2009,2010, respectively. Aggregate amortization for the five succeeding years from January 1, 20112012 through December 31, 20152016 is expected to be approximately $395,000, accumulating at the rate of $79,000 per year. The weighted average remaining life of the Company’s intangible assets is approximately 7.56.5 years.

The following schedule details the Company’s intangible asset balance by major asset class.


  At December 31, 2010 
  
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net Carrying
Amount
 
  (In thousands)
Customer-related $550  $(252) $298 
Completed technology  363   (167)  196 
Trademarks  187   (87)  100 
             
Total $1,100  $(506) $594 

  At December 31, 2009 
  
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net Carrying
Amount
 
  (In thousands) 
Customer-related $550  $(213) $337 
Completed technology  363   (141)  222 
Trademarks  187   (73)  114 
             
Total $1,100  $(427) $673 

  At December 31, 2011 
  Gross Carrying 
Amount
  Accumulated
Amortization
  Net Carrying 
Amount
 
  (In thousands) 
Customer-related $550  $(292) $258 
Completed technology  363   (193)  170 
Trademarks  187   (99)  88 
             
Total $1,100  $(584) $516 
  At December 31, 2010 
  Gross Carrying 
Amount
  Accumulated
Amortization
  Net Carrying 
Amount
 
  (In thousands) 
Customer-related $550  $(252) $298 
Completed technology  363   (167)  196 
Trademarks  187   (87)  100 
             
Total $1,100  $(506) $594 

6.Related Party Transactions

In March 2011, the maturity dates of a $1,500,000 Subordinated Convertible Promissory Note to Clarex Limited (“Clarex”) and a $1,000,000 Subordinated Convertible Promissory Note to an affiliate of Clarex were extended to April 1, 2013. The remaining terms and conditions of the notes were unchanged. These notes were previously issued on April 1, 2009 and had a maturity date of April 1, 2011. The notes bear interest at 6%. Interest accrues yearly, is payable on maturity and unpaid interest along with principal may be converted into securities of the Company as follows: The notes are convertible in the aggregate into 1,500,000 Units and 1,000,000 Units, respectively, with each unit consisting of one share of common stock and one warrant. Each warrant allows the holder to acquire 0.75 shares of common stock at a price of $1.35 per share and have an expiration date of April 2, 2016. Clarex is a significant shareholder of the Company.

The extensions of Subordinated Convertible Promissory Notes had no impact on the Company’s financial statements.
On March 30,

During 2011, the Company prepaidpaid the accrued interest of $202,500$645,000 and $135,000$480,000 on the $1,500,000 Note and the $1,000,000 Note, respectively.respectively that was outstanding as of December 31, 2010. In addition, the Company prepaid $150,000 for the interest that currently accrued on the Notes in 2011. The Company expects to continue to prepay its currently accruing quarterly interest obligations on the Notes of $37,500 going forward duringper quarter through the maturity date.

In May, 2008, Clarex exercised 200,000 warrants set to expire on May 18, 2008 for $216,000 and the Company issued 200,000 shares of its common stock.
In March, 2008, Clarex elected to exercise the 200,000 warrants expiring on March 31, 2008 and the Company issued 200,000 shares of its commons stock for proceeds of $85,000.
In January 2008, the Company repaid in full a $1,700,000 Secured Promissory Note held by Clarex, including accrued interest of $477,444.
date

7.Notes Payable - Other
 A note

Notes payable - Other consist of amounts payable to the U.S. Small Business Administration has a remaining balance of $344,874 as of December 31, 2010, bears interest at the rate of 4.0% and is due in 2032.

The remaining $125,000 balance of a $175,000 Note originally issued as part of the purchase of MRC on October 16, 2004, to the sole shareholder, along with accrued interest of $4,212 was paid in May 2009, prior to the maturity date.
An additional note with a remaining balance of $2,900 on December 31, 2008 was paid in May 2009.
32

Administration.

  December 31, 
  2011  2010 
  (rounded to the nearest 000’s) 
Notes payable - Other, payable in aggregate monthly installments of approximately $1,925 and bearing an interest rate of 4.0% and expiring in April 2032 $335,000  $345,000 
Less current portion  (10,000)  (9,000)
Notes payable - Other, excluding current portion $325,000  $336,000 

Notes payable - Other, consist of the following:

  December 31, 
  2010  2009 
Notes payable - Other, payable in aggregate monthly installments of approximately $1,925 and bearing an interest rate of 4.0% and expiring in April 2032. $345,000  $354,000 
Less current portion  (9,000)  (9,000)
Long-term debt, excluding current portion $336,000  $345,000 
Notes payable other, mature as follows:

Year ending December 31: 
2011 $9,000 
2012  9,400 
2013  9,800 
2014  10,200 
2015  10,600 
Thereafter  296,000 
  $345,000 

 Year ending December 31: 
 2011  $9,800 
 2012   10,200 
 2013   10,600 
 2014   11,100 
 2015   11,500 
 Thereafter   281,800 
    $335,000 

8.Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses are comprised of the following:

  December 31, 
  2011  2010 
  (In thousands) 
Trade accounts payable and accrued purchases $483  $424 
Accrued vacation  85   179 
Accrued payroll  102   87 
Accrued 401K common stock contribution  152   130 
Accrued expenses – other  56   16 
  $878  $836 

  December 31,
   2010  2009  
  (In thousands)
Trade accounts payable and accrued purchases $424  $328 
Accrued vacation  179   205 
Accrued payroll  87   63 
Net State income tax (prepaid) payable     (107)
Accrued 401K common stock contribution  130   155 
Accrued expenses – other  16   14 
  $836  $658 
33
9.Income Taxes

9.Income Taxes

The Company’s income tax benefit (provision)provision consists of the following:

  Years Ended 
  December 31, 
  2010  2009  2008 
Current:         
     Federal provision $  $  $(5,000)
     State provision        (100,000)
         (105,000)
Deferred:            
     Federal tax benefit        408,000 
     State         
         408,000 
Total $  $  $303,000 
33

  Years Ended 
  December 31, 
  2011  2010  2009 
          
Current:            
    Federal provision for AMT $6,000  $  $ 
    State provision  5,000       
   11,000       
Deferred:            
    Federal tax benefit         
    State         
          
Total $11,000  $  $ 

A reconciliation of the income tax provision computed at the statutory Federal income tax rate to our effective income tax rate follows (in percent):

  Years Ended 
  December 31, 
  2010  2009  2008 
Federal statutory rate  (34.0) %  (34.0) %  34.0%
State statutory rate  ( 7.4)  ( 6.5)  12.6 
Net operating loss carryforward - Federal        (34.0)
Federal AMT        0.6 
Expected tax benefit of net operating loss carryforward        (51.3)
Goodwill impairment charge     22.0    
Change in Valuation Allowance  37.0   13.4    
Prior year adjustments  4.4   5.1    
Effective income tax rate  %  %  (38.1) %

  Years Ended 
  December 31, 
  2011  2010  2009 
Federal statutory rate  34.0%  (34.0)%  (34.0)%
State statutory rate  8.0   (7.4)  (6.5)
Goodwill impairment charge        22.0 
Change in Valuation Allowance  (41.5)  37.0   13.4 
Permanent Differences  6.7       
Prior year adjustments     4.4   5.1 
Other  0.9       
Effective income tax rate  6.3%  %  %

At December 31, 2010,2011, the Company has estimated Federal and State net operating loss carry forwards of approximately $6,088,000$5,716,000 and $1,525,000,$1,164,000, respectively. These tax loss carry forwards expire at various dates through 2030.

2031.

Internal Revenue Code Section 382 places a limitation on the utilization of Federal net operating loss and other credit carry forwards when an ownership change, as defined by the tax law, occurs. Generally, this occurs when a greater than 50 percentage point change in ownership occurs. Accordingly, the actual utilization of the net operating loss and carryforwards for tax purposes may be limited annually to a percentage (based on the risk free interest rate) of the fair market value of the Company at the time of any such ownership change. The Company has not prepared an analysis of ownership changes but does not believe that a greater than 50% change of ownership has occurred and such limitations would not apply to the Company.

Deferred tax assets (liabilities) are comprised of the following:

  December 31, 
  2010  2009 
Account receivable reserves $7,000  $6,000 
Inventory reserves  528,000   593,000 
Inventory Capitalization  154,000   155,000 
Accrued vacation  76,000   86,000 
Depreciation  (154,000)  (245,000)
Loss carry forwards  2,176,000   1,921,000 
Gross deferred tax assets  2,787,000   2,516,000 
Valuation allowance  (2,379,000)  (2,108,000)
Net deferred tax asset $408,000  $408,000 

  December 31, 
  2011  2010 
       
Account receivable reserves $7,000  $7,000 
Inventory reserves  551,000   528,000 
Inventory capitalization  178,000   154,000 
Accrued vacation  36,000   76,000 
Depreciation  76,000   (154,000)
Loss carry forwards  2,012,000   2,176,000 
Gross deferred tax assets  2,860,000   2,787,000 
Valuation allowance  (2,452,000)  (2,379,000)
Net deferred tax asset $408,000  $408,000 
         

In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income that is consistent with the plans and estimates management is using to manage the underlying business. As of December 31, 20102011 and 2009,2010, the Company has a deferred tax asset of $408,000 which we estimate will be recoverable in future periods, net of a valuation allowance of $2,452,000 and $2,379,000, and $2,108,000, respectively.

We file

The Company files income tax returns in the United States, which typically provides for a three-year statute of limitations on assessments. However, because of net operating loss carryforwards, substantially all of our tax years remain open to federal tax examination.

The guidance for accounting for uncertainties in income taxes requires that we recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. There were no unrecognized tax benefits that impacted our effective tax rate and accordingly, there was no material effect to our financial position, results of operations or cash flows.

Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. To date, there have been no interest or penalties charged to us in relation to the underpayment of income taxes.

We do not anticipate that our unrecognized tax benefits will significantly increase in the next 12 months.

34

10.Equity Compensation Program and Stock-based Compensation
a.           2010 Equity Compensation Program

a.2010 Equity Compensation Program

The Company’s 2010 Equity Compensation Program was approved by the shareholders of the Company at the Annual Meeting which was held on June 2, 2010. The Company’s 2010 Equity Compensation Program provides for grants of options, stock appreciation rights and restricted stock awards to employees, officers, directors, and others who render services to the Company. The Program is comprised of four parts including: (i) the Incentive Stock Option Plan which provides for grants of “incentive stock options”, (ii) the Supplemental Stock Option Plan which provides for grants of stock options that shall not be “incentive stock options”, (iii) the Stock Appreciation Rights Plan which allows the granting of stock appreciation rights and, (iv) the Restricted Stock Award Plan which provides for the granting of restrictive shares of Common Stock and restricted stock units. The plans areplan is administered by the Compensation Committee of the Board of Directors. Under these plans,this plan, an aggregate of up to 4,000,000 shares of common stock may be granted.

b.           2000 Equity Compensation Program

b.2000 Equity Compensation Program

The Company’s 2000 Equity Compensation Program expired on June 2, 2010. All outstanding grants of options, stock appreciation rights and performance shares issued under the Program will remain outstanding and shall expire on the date determined by the terms of the original grant. The latest date of expiration for outstanding grants under the plan is September 13,March 28, 2020.

c.           Stock Option Expense

c.Stock Option Expense

The Company’sCompany's results for the years ended December 31, 2011, 2010 2009 and 20082009 include stock-based compensation expense for stock option grants totaling $165,000, $127,000 $65,000 and $47,000,$65,000, respectively. Such amounts have been included in the Consolidated Statements of Operations within cost of goods sold ($48,00068,000 for 2011, $48,000 for 2010 and $7,000 for 2009 and $8,000 for 2008)2009), and selling, general and administrative expenses ($79,00097,000 for 2011, $79,000 for 2010 and $58,000 for 2009 and $39,000 for 2008)2009).

As of December 31, 2011, 2010 2009 and 2008,2009, there were $382,300, $194,300 $311,300 and $17,000$311,300 of unrecognized compensation costs, net of estimated forfeitures, related to non-vested stock options, which are expected to be recognized over a weighted average period of approximately 2.3 years, 2.3 years and 3.0 years, and 1.1 years, respectively.

The weighted average estimated fair value of stock options granted in the twothree years ended December 31, 2011, 2010 and 2009 was $0.86, $1.00 and $1.22, respectively. The fair value of options at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of our stock and other contributing factors. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The expected term is based upon the contractual term of the option.

The following range of weighted-average assumptions were used for to determine the fair value of stock option grants during the years ended December 31, 2011, 2010 and 2009:


  Years Ended 
  December 31, 
  2010  2009  2008 (1) 
Dividend yield  %  %  %
Volatility  226 - 236%  180 - 232%  %
Risk-free interest rate  2.7 - 3.7%  2.5 - 3.45%  %
Expected life 10 years  10 years    

  Years Ended 
  December 31, 
  2011  2010  2009 
Dividend yield      
Volatility  94 – 100
  226 - 236  180 - 232
Risk-free interest rate  2.0 - 3.4  2.7 - 3.7  2.5 - 3.45
Expected life  10 years   10 years   10 years 
(1)d.The Company did not issue any stock options during 2008.Stock Option Activity
35

d.           Stock Option Activity

A summary of the Company’s outstanding stock options as of and for the years ended December 31, 2011, 2010 2009 and 20082009 is presented below:


  Options 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(In Years)
 
Aggregate
Intrinsic
Value(a)
 
Outstanding as of January 1, 2008 1,228,639 $         1.52      
Granted         
Exercised (182,000) 1.42      
Forfeited /Expired (16,500) 3.25      
Outstanding as of December 31, 2008 1,030,139  1.50      
Granted 305,084  1.22      
Exercised (84,500) 1.14      
Forfeited/Expired (35,000) 1.10      
Outstanding as of December 31, 2009 1,215,723  1.46      
Granted 10,000  1.00      
Exercised (10,000) .85      
Forfeited /Expired (417,247) 2.11      
Outstanding as of December 31, 2010(b)
 798,476 1.13 5.2  $63,105 
            
Exercisable as of December 31, 2010 543,951 1.12 3.5  $63,105 

  Options  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Term
(In Years)
  Aggregate
Intrinsic
Value(a)
 
Outstanding as of January 1, 2009  1,030,139  $1.50         
Granted  305,084   1.22         
Exercised  (84,500)  1.14         
Forfeited/Expired  (35,000)  1.10         
Outstanding as of December 31, 2009  1,215,723   1.46         
Granted  10,000   1.00         
Exercised  (10,000)  .85         
Forfeited/Expired  (417,247)  2.11         
Outstanding as of December 31, 2010  798,476   1.13         
Granted  409,000   .97         
Exercised  (20,000)  .95         
Forfeited /Expired  (108,400)  1.66         
Outstanding as of December 31, 2011(b)  1,079,676  $1.02   6.7  $63,105 
                 
Exercisable as of December 31, 2011  578,086  $1.03   4.6  $63,105 

(a) Intrinsic value for purposes of this table represents the amount by which the fair value of the underlying stock, based on the respective market prices as of December 31, 20102011 exceeds the exercise prices of the respective options.


All of the options used in the calculation of the aggregate intrinsic value for outstanding options are exercisable as of December 31, 2011.

(b) Based on the Company’s historical forfeiture rate, the number of options expected to vest is the same as the total outstanding at December 31, 2010.

2011.

The following table represents non-vested stock options granted, vested, and forfeited for the year ended December 31, 2010.

Non-vested Options Options  Weighted-Average Grant-Date Fair Value 
Non-vested  - January 1, 2010  300,728  $1.21 
Granted  10,000  $1.00 
Vested  (36,373) $1.64 
Forfeited  (19,830) $1.14 
Non-vested – December 31, 2010  254,525  $1.14 
2011.

Non-vested Options Options  Weighted-Average Grant-Date
Fair Value - $
 
Non-vested  - January 1, 2011  254,525   1.14 
Granted  409,600   .86 
Vested  (157,135)  1.11 
Forfeited  (5,400)  .91 
Non-vested – December 31, 2011  501,590   .92 

The total fair value of options vested during the years ended December 31, 2011, 2010 and 2009, was $175,100, $59,600 and 2008, was $59,600, $49,000, and $35,000, respectively.

36

The following table summarizes information about stock options outstanding at December 31, 2010:

 Options Outstanding Options Exercisable 
   Weighted       
   Average Weighted   Weighted 
   Remaining Average   Average 
Range ofNumber Contractual Exercise Number Exercise 
Exercise Price (1) Outstanding Life in Years Price Outstanding Price 
$0.50 - $1.75 775,876 8.8 $1.04 521,351 $0.98 
$3.25 - $5.00 22,600 0.5 $4.34 22,600 $4.34 

2011:

  Options Outstanding  Options Exercisable 
     Weighted          
     Average  Weighted     Weighted 
     Remaining  Average     Average 
Range of Number  Contractual  Exercise  Number  Exercise 
Exercise Price Outstanding  Life in Years  Price  Outstanding  Price 
$0.50 - $1.03  912,700   6.9  $0.91   437,607  $0.84 
$1.20 - $1.75  166,976   6.0  $1.61   140,479  $1.60 

(1) There were no outstanding options with an exercise price between $1.75 and $3.25.e.Restricted Stock Unit Awards
e.           Restricted Stock Unit Awards
There were no Restricted Stock Unit awards in 2010 and 2009.  

During 2008,2011, the Company granted 23,50015,000 restricted stock units under the 20002010 Performance Share Program with an estimated fair value of $85,300$14,550 based on the closing market price of the Company’s stock on the grant date. These grants vest over a three year period contingent on continued employment over the vesting period. The Company recognized related stock compensation expense of $7,000 ($0 in Cost of Goods Sold and $7,000 in Selling, General and Administrative expenses) in 2011, $41,000 ($5,000 in Cost of Goods Sold and $36,000 in Selling, General and Administrative expenses) in 2010 and $48,000 ($5,000 in Cost of Goods Sold and $43,000 in Selling, General and Administrative expenses) in 2009, and $41,000 ($5,000 in Cost of Goods Sold and $36,000 in Selling, General and Administrative expenses) in 2008, related to these and previously issued grants.


There were no Restricted Stock Unit awards in 2010 and 2009.

A summary of the Company’s non-vested restricted stock unit awards shares is as follows:


  # of Units  
Weighted Average
Grant Date
Fair Value
$
 
Outstanding as of January 1, 2008  12,000   4.00 
Granted  23,500   3.63 
Vested  (4,000)  4.00 
Forfeited/Expired      
Outstanding as of December 31, 2008  31,500   3.72 
Granted        
Vested  (13,504)  3.79 
Forfeited/Expired      
Outstanding as of December 31, 2009  17,996   3.68 
Granted      
Vested  (6,998)  3.59 
Forfeited/Expired  (4,000)  4.00 
Outstanding as of December 31, 2010  6,998   3.59 

  # of Units  Weighted Average
Grant Date
Fair Value
$
 
       
Outstanding as of January 1, 2009  31,500   3.72 
Granted      
Vested  (13,504)  3.79 
Forfeited/Expired      
Outstanding as of December 31, 2009  17,996   3.68 
Granted      
Vested  (6,998)  3.59 
Forfeited/Expired  (4,000)  4.00 
Outstanding as of December 31, 20010  6,998   3.59 
Granted  15,000   .97 
Vested  (6,998)  3.59 
Forfeited/Expired      
Outstanding as of December 31, 2011  15,000   .97 

The total fair value of restricted stock units which vested during 2011, 2010 and 2009 was $6,900, $8,500 and 2008 was $8,487, $20,774 and $6,600,$20,800, respectively, as of the vesting date.


On March 24, 2011, the Company granted to directors, officers and existing employees an aggregate of 200,900 options to purchase the Company’s common stock under the 2010 Equity Compensation Program. Each such option is exercisable for a period of ten years from the date of the grant and granted at an exercise price of $0.98 per share.

11.Net Income (Loss) Income per Share

Basic income (loss) income per common share is computed by dividing net income (loss) income by the weighted average number of common shares outstanding. Diluted income (loss) income per common share is computed by dividing net income (loss) income by the weighted average number of common shares and common stock equivalents outstanding, calculated on the treasury stock method for options, stock grants and warrants using the average market prices during the period, including potential common shares issuable upon conversion of outstanding convertible notes, except if the effect on the per share amounts is anti-dilutive.For the year ended December 31, 2011, a total of 94,778 common share equivalents were assumed to be outstanding at the end of the year. A total of 2,500,000 anti-dilutive common shares issuable upon conversion of outstanding convertible notes have been excluded from the diluted computation because their effect is anti-dilutive.

For the year ended December 31, 2010 and 2009, all common equivalent shares outstanding have been excluded from the diluted computation because their effect is anti-dilutive.

37

This included a weighted average of 2,500,000 anti-dilutive common shares issuable upon conversion of outstanding convertible notes and 1,125,000 anti-dilutive common shares issuable on conversion of accrued interest. The weighted average number of outstanding anti-dilutive warrants excluded from the computation of diluted net income per common share year ended December 31, 2010 was 2,718,750 and the weighted average number of outstanding anti-dilutive common stock options was 798,476. In addition, a total weighted average of 6,998 shares of non-vested restricted stock with a grant date fair value in excess of the average market price of the common shares during the year was excluded from the computation because their effect is anti-dilutive.

A reconciliation of the shares used in the calculation of basic and diluted earnings per common share is as follows:

  Years ended December 31, 
  2010  2009  2008 
Numerators         
Net (loss) income applicable to common shareholders - basic $(733,813) $(2,799,992) $1,098,421 
Interest on Convertible Debt        150,000 
Net (loss) income applicable to common shareholders - diluted $(733,813) $(2,799,922) $1,248,421 
             
Denominators            
Weighed average shares outstanding-Basic  11,522,297   11,331,258   10,902,061 
Convertible Debt        2,500,000 
Warrants        1,615,417 
Stock options        594,972 
Restricted stock units        6,854 
Weighted average shares outstanding - diluted  11,522,297   11,331,258   15,619,304 

  Years ended December 31, 
  2011  2010  2009 
Numerators            
             
Net income (loss) applicable to common shareholders - basic $164,786  $(733,813) $(2,799,992)
Interest on Convertible Debt         
Net income (loss) applicable to common shareholders - diluted $164,786  $(733,813) $(2,799,922)
             
Denominators            
             
Weighted average shares outstanding-basic  11,658,891   11,522,297   11,331,258 
Stock options  83,843       
Restricted stock units  10,935       
Weighted average shares outstanding – diluted  11,753,669   11,522,297   11,331,258 

12. 12.Commitments

a.
Lease commitments

The Company occupies approximately 42,000 square feet of space located at 181 Legrand Avenue, Northvale, New Jersey pursuant to a net lease. Under the terms of the lease, the Company is obligated for all real estate taxes, maintenance and operating costs of the facility. On November 1, 2010,2011, the Company exercisednegotiated a change to the finalrate on its Northvale lease and extended the term until October 31, 2013. The Company also has the option onof renewing the lease extending the term for an additional two years toone year, at fixed terms, through October 31, 2012, at substantially the same terms.

2014.

The Company’s wholly-owned subsidiary, MRC Precision Metal Optics, subsidiaryInc., occupies approximately 25,000 square feet of space located at 6405 Parkland Drive, Sarasota, FL pursuant to a net lease originally expiring on August 31, 2006. Under the terms of the lease, the Company is obligated for all real estate taxes, maintenance and operating costs of the facility. During 2006, MRC Opticsthe Company negotiated terms for the renewal of the lease until August 31, 2008 and in 2008, the Company elected to extend the lease until August 31, 2010. In August 2010, the Company negotiated terms for the renewal of the lease until August 31, 2013.

The total rent for these leases was approximately $519,000, $569,000 and $582,000 in 2011, 2010 and $588,000 in 2010, 2009, and 2008, respectively.

Future minimum annual rentals which cover the remaining lease terms, excluding uncommitted option renewal periods are as follows:


Year ending December 31: 
2011 $480,000 
2012  428,000 
2013  107,000 
  $1,105,000 
38

Year ending December 31: 
2012  $440,000 
2013   393,000 
2014   253,000 
   $1,086,000 

b.Retirement plans

The Company maintains a 401(k) savings plan (the “Plan”) for all eligible employees (as defined in the plan). The 401(k) plan allows employees to contribute up to 20% of their compensation on a salary reduction, pre-tax basis up to the statutory limitation. The 401(k) plan also provides that the Company, at the discretion of the Board of Directors, may match employee contributions based on a pre-determined formula.

In 2011, the Company matched employee contributions of $151,775 in the form of 152,460 shares of the Company’s common stock, which were issued to the Plan in March 2012. In 2010, the Company matched employee contributions of $129,998 in the form of 124,669 shares of the Company’s common stock, which were issued to the Plan in March 2011. In 2009, the Company matched employee contributions of $154,535 in the form of 103,403 shares of the Company’s common stock, which were issued to the Plan in March 2010. In 2008, the Company matched employee contributions in the amount of $179,068 contributed in the form of 66,469 shares of the Company’s common stock, distributed in February 2009.  The Company records the distribution of the common shares in the Consolidated Statement of Shareholders’ Equity as of the date of distribution to the 401(k) plan administrator.

38
13. 

13.Product Sales, Foreign Sales and Sales to Major Customers

The following table summarizes the Company’s productnet sales by product categories during the past three years:


Year Ended December 31, 2010  2009  2008 
Category Sales  %  Sales  %  Sales  % 
Optical Components $10,115,000   92  $10,350,000   94  $14,750,000   90 
Laser System Devices and Instrumentation  939,000   8   701,000   6   1,551,000   10 
Total $11,054,000   100  $11,051,000   100  $16,301,000   100 

Year Ended December 31, 2011  2010  2009 
Category Net Sales  %  Net Sales  %  Net Sales  % 
Optical Components $11,812,000   90  $10,115,000   92  $10,350,000   94 
Laser System Devices and Instrumentation  1,365,000   10   939,000   8   701,000   6 
Total $13,177,000   100  $11,054,000   100  $11,051,000   100 

The Company’s export sales, which are primarily to customers in countries within Europe, Asia and Japan, amounted to approximately 14.9%22.8%, 12.5%14.9%, and 5.2%12.5% of product sales in 2011, 2010 and 2009, and 2008, respectively

The Company had sales to three major domestic customers which accounted for 15.3%20.9%, 15.4% and 10.8%, and 10.3% of sales in 2010.  Each customer2011. The largest is an international customer that is in the process control and metrology industry. Both of the other major customers are electro-optical systems divisiondivisions of a major U.S. defense corporationindustry corporations who manufactures systems for U.S. and allied foreign governments. In 2010, the same three customers represented 10.1%, 10.3% and 15.3% of sales, respectively. In 2009, the same three customers represented 17.7%5.5%, 9.8%4.7% and 4.7%17.7% of sales, respectively.  In 2008, the same three customers represented 8.7%, 5.9% and 9.6% of sales, respectively.

During the past three years, sales to the Company’s top five customers represented approximately 53.3%58.1%, 55.3%54.3% and 58.8%55.3% of sales, respectively. Given the concentration of sales within a small number of customers, the loss of any of these customers would have a significant negative impact on the Company and its business units.

14.Shareholders’ Equity

a.Common shares reserved at December 31, 2010,2011, are as follows:

2010 Equity compensation plan  4,000,000 
2000 Equity compensation plan  800,474669,676 
Subordinated convertible notes  2,500,000 
Accrued interest convertible to common shares1,125,000
Warrants issuable on conversion of Subordinated convertible notes and accrued interest  2,718,7501,875,000 
   11,144,2249,044,676 

b.
Warrants

The Company had no outstanding warrants as of December 31, 2011 and 2010. As of December 31, 2009, the Company had 60,000 outstanding warrants with an exercise price of $1.35 and a fair value of $1.31 which expired in May 2010. During the year ended December 31, 2009, a total of 50,000 warrants were exercised with a fair value of $1.29 and an exercise price of $1.35 each or $67,500, in total. A total of 893,790 warrants with an exercise price of $1.35 and fair value of $1.29 expired during the year.

39

in 2009.

15.
Fair Value of Financial Instruments

The methods and assumptions used to estimate the fair value of the following classes of financial instruments were:

Current Assets and Current Liabilities: The carrying amount of cash, certificates of deposits, current receivables and payables and certain other short-term financial instruments approximate their fair value as of December 31, 20102011 due to their short-term maturities.

Long-Term Debt: The fair value of the Company’s long-term debt, including the current portion, for notes payable and subordinated convertible debentures, was estimated using a discounted cash flow analysis, based on the Company’s assumed incremental borrowing rates for similar types of borrowing arrangements. The carrying amount of variable and fixed rate debt at December 31, 20102011 in the amount of $3,970,000$2,835,000 approximates fair value.

16.
Quarterly Data (Unaudited)

Summary quarterly results were as follows:

Year 2011 First  Second  Third  Fourth 
             
Net sales $3,241,434  $3,221,234  $3,328,761  $3,385,765 
Gross profit  872,537   784,060   907,905   997,817 
Net income (loss)  34,729   (95,750)  83,731   142,036 
Net income (loss) per share - Basic  0.00   (0.01)  0.01   0.01 
Net income (loss) per share – Diluted  0.00   (0.01)  0.01   0.01 

Year 2010 First  Second  Third  Fourth 
             
Net sales $2,808,046  $2,164,491  $2,478,581  $3,603,060 
Gross profit  540,494   255,712   494,678   1,218,141 
Net loss  (274,469)  (648,898)  (281,755)  471,309 
Net loss per share - Basic  (0.02)  (0.06)  (0.02)  0.04 
Net loss per share - Diluted  (0.02)  (0.06)  (0.02)  0.04 

Year 2009 First  Second  Third  Fourth 
             
Net sales $2,815,097  $2,620,437  $2,664,963  $2,950,630 
Gross profit  381,687   419,098   606,530   747,273 
Net loss  (314,409)  (336,998)  (2,122,330)  (26,225)
Net loss per share - Basic  (0.03)  (0.03)  (0.19)  (0.00)
Net loss per share - Diluted  (0.03)  (0.03)  (0.19)  (0.00)

40
Year 2010 First  Second  Third  Fourth 
Net sales $2,808,046  $2,164,491  $2,478,581  $3,603,060 
Gross profit  540,494   255,712   494,678   1,218,141 
Net income (loss)  (274,469)  (648,898)  (281,755)  471,309 
Net income (loss) per share - Basic  (0.02)  (0.06)  (0.02  0.04 
Net income (loss) per share – Diluted  (0.02)  (0.06)  (0.02)  0.04 

Year 2009 First  Second  Third  Fourth 
Net sales $2,815,097  $2,620,437  $2,664,963  $2,950,630 
Gross profit  381,687   419,098   606,530   747,273 
Net loss  (314,409)  (336,998)  (2,122,330)  (26,255)
Net loss per share - Basic  (0.03)  (0.03)  (0.19)  (0.00)
Net loss per share - Diluted  (0.03)  (0.03)  (0.19)  (0.00)

Year 2008 First  Second  Third  Fourth 
Net sales $4,164,248  $4,007,412  $3,802,935  $4,326,614 
Gross profit  1,501,593   1,219,202   1,065,424   1,028,370 
Net income  491,200   294,017   169,120   144,084 
Net income per share - Basic  0.05   0.03   0.02   0.01 
Net income per share - Diluted  0.03   0.02   0.01   0.01 
40

Schedule II –Valuation and Qualifying Accounts


PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC.

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

  Balance at
Beginning
of Period
  Charged
(Credited)
to Expenses
  Additions
(Deductions) 
to Other 
Accounts
  Deductions  Balance
at End of
Period
 
Allowance for Doubtful Accounts                    
Year ended December 31, 2011 $15,000           $15,000 
Year ended December 31, 2010 $15,000           $15,000 
Year ended December 31, 2009 $15,000           $15,000 
                     
Valuation Allowance for Deferred Tax Assets                    
Year ended December 31, 2011 $2,379,000      73,000     $2,452,000 
Year ended December 31, 2010 $2,108,000      271,000     $2,379,000 
Year ended December 31, 2009 $1,733,000      375,000     $2,108,000 

41
  
Balance at
Beginning
of Period
  
Charged
(Credited)
to Expenses
  
Additions (Deductions)
to Other
Accounts
  Deductions  
Balance
at End of
Period
 
Allowance for Doubtful Accounts               
Year ended December 31, 2010 $15,000           $15,000 
Year ended December 31, 2009 $15,000           $15,000 
Year ended December 31, 2008 $15,000           $15,000 
                     
Valuation Allowance for Deferred Tax Assets                    
Year ended December 31, 2010 $2,108,000      271,000     $2,379,000 
Year ended December 31, 2009 $1,733,000      375,000     $2,108,000 
Year ended December 31, 2008 $2,041,000   (408,000)  100,000     $1,733,000 
41